WO2023073922A1 - Oral product containing indigestible dextrin and composition for said product - Google Patents

Oral product containing indigestible dextrin and composition for said product Download PDF

Info

Publication number
WO2023073922A1
WO2023073922A1 PCT/JP2021/040024 JP2021040024W WO2023073922A1 WO 2023073922 A1 WO2023073922 A1 WO 2023073922A1 JP 2021040024 W JP2021040024 W JP 2021040024W WO 2023073922 A1 WO2023073922 A1 WO 2023073922A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
product
composition
oral
indigestible dextrin
Prior art date
Application number
PCT/JP2021/040024
Other languages
French (fr)
Japanese (ja)
Inventor
健 濱本
Original Assignee
日本たばこ産業株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日本たばこ産業株式会社 filed Critical 日本たばこ産業株式会社
Priority to PCT/JP2021/040024 priority Critical patent/WO2023073922A1/en
Publication of WO2023073922A1 publication Critical patent/WO2023073922A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Definitions

  • the present invention relates to oral compositions containing indigestible dextrin and compositions for such products.
  • Type II diabetes is a typical adult disease, and it is known that it is important to prevent a rapid increase in blood sugar levels as a preventive measure.
  • ingestion of indigestible dextrin after a meal suppresses a rapid increase in blood sugar level.
  • Non-Patent Document 1 discloses that a beverage containing indigestible dextrin can suppress the increase in postprandial blood glucose level.
  • an object of the present invention is to provide a novel form of product containing indigestible dextrin.
  • Aspect 1 nicotine or a nicotine-containing raw material (A) and an indigestible dextrin (B), A composition for oral products, in which 3 to 7 parts by weight of the indigestible dextrin can be ingested with respect to 100 parts by weight of the glucose during or after the ingestion of glucose.
  • Aspect 2 An oral product containing the composition according to aspect 1, wherein the weight of the indigestible dextrin (B) per product is 3-9 g.
  • Aspect 3 An oral product containing the composition according to aspect 1, wherein the weight of the indigestible dextrin (B) per product is 0.5-1 g.
  • Aspect 4 a main material containing nicotine or a nicotine-containing raw material (A); and an exterior material provided outside the main material, The exterior material or the main material further contains indigestible dextrin (B), The amount of the indigestible dextrin (B) is 3 to 9 g in the product, oral products.
  • Aspect 5 a main material containing nicotine or a nicotine-containing raw material (A); and an exterior material provided outside the main material, The exterior material or the filling further contains a non-digestible dextrin (B), The amount of the indigestible dextrin (B) is 0.5 to 1 g in the product, oral products.
  • Aspect 6 4.
  • Aspect 7 An oral product according to aspect 2 or 4 in the form of a gum or tablet.
  • Aspect 8 An oral product according to aspect 3 or 5, which is in the form of a pouch.
  • Aspect 9 A method of ingesting a product according to any of aspects 2-8, comprising: A method of ingestion, comprising ing 3 to 7 parts by weight of the indigestible dextrin with respect to 100 parts by weight of the glucose during or after the ingestion of glucose.
  • a new form of product containing indigestible dextrin can be provided by the present invention.
  • X to Y includes X and Y which are the end values.
  • Oral products are products in which active ingredients are ingested through the oral mucosa via saliva while the product is contained in the oral cavity. Oral products do not involve burning or heating or atomization by devices when used.
  • composition for oral products contains nicotine or a nicotine-containing raw material as component (A) and indigestible dextrin as component (B).
  • Compositions for oral products contain nicotine or nicotine-containing raw materials as component (A).
  • the compound may contain nicotine as a compound, or nicotine-containing raw materials such as nicotine salts and stabilized nicotine.
  • Examples of stabilized nicotine include nicotine-carrying substances such as nicotine carried on ion-exchange resins.
  • ion exchange resins include weakly acidic cation exchange resins.
  • As the nicotine-supported ion exchange resin a resin complex containing nicotine in an amount of 10% by weight or more and 20% by weight or less, specifically called nicotine polacrilex, can be used.
  • the ion exchange resin used in nicotine polacrilex is a weakly acidic cation exchange resin.
  • the amount added to the composition is usually 0.5% by weight or more, preferably 1.0% by weight or more, and more preferably 2.0% by weight or more.
  • the amount of nicotine polacrilex added to the composition is usually 15.0% by weight or less, preferably 12.0% by weight or less, and 10.0% by weight or less. is more preferable.
  • the nicotine-containing raw material may be a tobacco material containing, for example, tobacco powder obtained by pulverizing tobacco leaves.
  • Tobacco powder may include dried tobacco leaf lamina cuts, fines, or fibers, and is prepared, for example, by the method described below.
  • tobacco leaves may include mesophyll (lamina), veins (stem), or roots.
  • the tobacco material may contain tobacco powder, which is basically obtained from tobacco leaf lamina, as well as elements derived from tobacco leaf backbones and roots.
  • the particle size of the tobacco powder is not limited, but from the viewpoint of improving the familiarity in the oral cavity and enhancing the feeling of use, and from the viewpoint of improving the release of the flavoring ingredients contained in the tobacco powder into the oral cavity, it is recommended to use a particle size of 1.2 mm. It is preferably one that has passed through a mesh, and more preferably one that has passed through a 1.0 mm mesh.
  • the tobacco species used as the raw material for the tobacco powder is not particularly limited, and examples thereof include Nicotiana tabacum yellow variety, Burley variety, and Nicotiana rustica Brasilia variety. The same species can be used for tobacco materials and tobacco leaves, which will be described later.
  • tobacco powder is preferably prepared as follows. First, a base is added to and mixed with tobacco powder obtained by pulverizing tobacco leaves. Examples of the base to be added include potassium carbonate and sodium carbonate, which are preferably added as an aqueous solution. Also, a pH adjuster such as sodium dihydrogen phosphate may be added, for example, to stabilize nicotine during the production of oral pouch products. The pH of the mixture after addition of the base is preferably adjusted to 8.0-9.0. The content of tobacco powder in this mixture is preferably 60 to 90% by weight.
  • a base is added to and mixed with tobacco powder obtained by pulverizing tobacco leaves. Examples of the base to be added include potassium carbonate and sodium carbonate, which are preferably added as an aqueous solution.
  • a pH adjuster such as sodium dihydrogen phosphate may be added, for example, to stabilize nicotine during the production of oral pouch products.
  • the pH of the mixture after addition of the base is preferably adjusted to 8.0-9.0.
  • the content of tobacco powder in this mixture is preferably 60
  • the mixture After adding the base, the mixture is heated, for example, for 0.5 to 3 hours, preferably 0.8 to 2 hours, under conditions such that the product temperature is 65 to 90°C, preferably 70 to 80°C.
  • Heating can be accomplished by steam injection heating, jacket heating, or both.
  • the pH of the mixture after heating is preferably 8.0 to 9.0, and the water content of the mixture after heating is preferably 10 to 50% by weight.
  • the steam injection is stopped and only the jacket is heated to dry the treated tobacco powder obtained. After that, it can be cooled at about 15 to 25° C. for about 1 hour.
  • the amount added to the composition is usually 0.001% by weight or more, preferably 0.01% by weight or more, and 0.05% by weight or more. is more preferred.
  • the amount added to the composition is usually 90% by weight or less, preferably 80% by weight or less, 70% by weight or less, 45% by weight or less, 40% by weight or less, or 30% by weight. It is below.
  • the nicotine-containing raw material may be a nicotine-containing extract obtained by extracting nicotine-containing substances such as tobacco leaves.
  • a nicotine-carrying substance from the viewpoint of accurate nicotine supply and ease of handling.
  • the composition or oral product generally tends to take on the color of tobacco leaves.
  • a colorless nicotine-containing compound it is possible to provide white compositions and oral products.
  • Such an aspect is an advantage for users who prefer white oral products.
  • One of the raw materials described above as the component (A) may be used alone, or two or more thereof may be used in combination.
  • the content of total nicotine in the composition is not limited, it is usually 0.1 to 15.0% by weight from the viewpoint of user's preference. Therefore, when a nicotine-containing raw material is used as component (A), the amount of the raw material is adjusted so that the total nicotine content falls within this range.
  • the above content is the content as nicotine ions.
  • the content of nicotine in the composition can be measured by gas chromatography-mass spectrometer (GC-MS), liquid chromatography (LC, UV detection), or the like.
  • the oral product composition contains indigestible dextrin as component (B).
  • Indigestible dextrin is obtained by 1) adding a trace amount of acid to starch and heat-treating it to obtain roasted dextrin, 2) allowing an enzyme that cleaves the bond between glucose to act on the roasted dextrin, and 3) by the treatment. It can be produced by purifying the dextrin portion that has not been decomposed into glucose (Tomoko Sasaki, Sugar/Starch Information 2018.2, p2).
  • the indigestible dextrin is a dextrin having an average molecular weight of about 2000 and a DE (dextrose equivalent) of about 20 or less, which is an index of starch hydrolysis.
  • Specific examples of indigestible dextrin include "Fibersol 2" commercially available from Matsutani Chemical Industry Co., Ltd., and the like.
  • Indigestible dextrin can exert its function as dietary fiber. That is, it is understood that ingredients that are quantified as dietary fiber work as active ingredients, although ingredients that do not function as dietary fiber may exist in commercially available raw material products. Therefore, the term "indigestible dextrin" in the present invention refers to indigestible dextrin that functions as dietary fiber. For example, in a mixture such as a commercial product, the indigestible dextrin detected as dietary fiber is the "indigestible dextrin" in the present invention. Since the main component of the indigestible dextrin that functions as dietary fiber can be trisaccharide, the average molecular weight of the indigestible dextrin is 500-2000 in one embodiment. A method for analyzing indigestible dextrin will be described in detail separately.
  • the indigestible dextrin used as dietary fiber has a low molecular weight as described above, it can be quantified relatively easily from the composition by the enzyme-HPLC method.
  • the method for analyzing and quantifying the indigestible dextrin is not limited as long as it can be appropriately analyzed and quantified, and a person skilled in the art can quantify using any method. A method that goes through each step is preferable.
  • thermostable ⁇ -amylase After dissolving the sample, it is digested with thermostable ⁇ -amylase. It is then further digested with amyloglucosidase. If necessary, the protein in the sample is degraded by protease. After that, ethanol is added to generate a precipitate, which is separated into a filtrate and a precipitate by suction filtration. After concentrating the filtrate with a rotary evaporator, protein degradation products, organic acids, inorganic salts and the like are removed with an ion exchange resin, and subjected to high performance liquid chromatography (HPLC).
  • HPLC high performance liquid chromatography
  • the dietary fiber fraction (trisaccharides or higher) from the monosaccharide and disaccharide fractions on the obtained chromatograph, and determine the peak area ratio of the dietary fiber fraction and glucose.
  • glucose as an internal standard substance, the amount of low-molecular-weight water-soluble dietary fiber is calculated by multiplying the peak area ratio by the weight of glucose.
  • the peak elution position of maltotriose, one of the trisaccharides is used as an indicator, and the dietary fiber fraction is quantified by eluting at or before this peak.
  • composition for oral products contains an amount of indigestible dextrin that allows ingestion of 3 to 7 parts by weight of indigestible dextrin per 100 parts by weight of glucose during or after ingestion of glucose.
  • the amount of component (B) is the amount of indigestible dextrin that functions as dietary fiber.
  • the content of component (B) in the composition should be an amount that allows 3 to 7 parts by weight of component (B) to be ingested per 100 parts by weight of glucose.
  • the content of component (B) in the composition is preferably 300 to 700 parts by weight with respect to 1 part by weight of nicotine.
  • the composition preferably contains a substrate.
  • the substrate is not particularly limited, and examples thereof include polysaccharides and porous structures capable of adsorbing and retaining moisture.
  • the substrate is preferably one or more selected from the group consisting of cellulose, microcrystalline cellulose (MCC), spherical cellulose, and porous cellulose.
  • MCC microcrystalline cellulose
  • spherical cellulose a polysaccharide
  • porous cellulose preferably one or more selected from the group consisting of cellulose, microcrystalline cellulose (MCC), spherical cellulose, and porous cellulose.
  • MCC microcrystalline cellulose
  • spherical cellulose spherical cellulose
  • porous cellulose cellulose is more preferable from the viewpoint of flexibility in adjusting the bulk density of the composition and exhibiting white color.
  • One type of these substances may be used alone, or two or more types may be used in combination at any ratio.
  • the content of the base material in the composition is not limited. However, from the viewpoint of improving quality by suppressing the elution of water during manufacturing or product storage, and from the viewpoint of imparting a desirable appearance to users by increasing the whiteness of the product, the content is usually 10% by weight. % or more, preferably 15% by weight or more, more preferably 20% by weight or more.
  • the upper limit of the content is not limited, it is usually 70% by weight or less, preferably 68% by weight or less, more preferably 65% by weight or less, from the viewpoint of the limit that can be blended with other raw materials. preferable.
  • the composition preferably contains a sugar alcohol.
  • the type of sugar alcohol is not particularly limited, and examples thereof include xylitol, maltitol, erythritol, sorbitol, mannitol, and lactitol. Among these, maltitol is preferable from the viewpoint of imparting good flavor.
  • One type of these substances may be used alone, or two or more types may be used in combination at any ratio.
  • the content of sugar alcohols in the composition is not limited, but from the viewpoint of flavor adjustment, it is usually 1% by weight or more. % or more, and more preferably 10% or more by weight. Moreover, the upper limit is usually 80% by weight or less, preferably 70% by weight or less, and more preferably 60% by weight or less.
  • the composition preferably contains a polyglycerin fatty acid ester.
  • the degree of polymerization of glycerin in the polyglycerol fatty acid ester is preferably 2-10.
  • Polyglycerin fatty acid ester functions as an emulsifier. Therefore, by containing the polyglycerol fatty acid ester, a uniform mixing state of each component of the composition can be maintained, and the flavor component can be kept stable, so that the flavor of the composition can be improved.
  • the polyglycerol fatty acid ester imparts an appropriate viscosity to the composition, and can bind each component together, thereby suppressing dryness of the composition and improving the feeling of use, flavor, etc. be able to.
  • composition is a dry type with a low water content (moisture content)
  • moisture content moisture content
  • scattering of the composition can be suppressed when filling the composition into an exterior material such as a pouch.
  • Polyglycerin fatty acid ester is a fatty acid ester of a dehydration condensate of glycerin, and the degree of polymerization of glycerin is usually 2 or more, may be 3 or more, and is usually 10 or less, and may be 8 or less. good.
  • the fatty acid ester group (RCOO- group) of polyglycerin fatty acid ester is derived from fatty acid.
  • the fatty acid is not limited and may be a saturated fatty acid or an unsaturated fatty acid.
  • the carbon number of the fatty acid is usually 10 or more, preferably 12 or more, more preferably 14 or more, and further preferably 16 or more, from the viewpoint of good flavor and production efficiency. Also, it is usually 30 or less, preferably 26 or less, more preferably 22 or less, and even more preferably 20 or less.
  • the fatty acid may have a substituent or may be unsubstituted.
  • the number of fatty acid ester groups possessed by one polyglycerin fatty acid ester molecule is not limited as long as the polyglycerin fatty acid ester has a structure capable of exhibiting a function as an emulsifier, depending on the degree of polymerization of glycerin and the number of hydroxyl groups derived from glycerin. It can be selected as appropriate.
  • a structure capable of functioning as an emulsifier is a structure having both a fatty acid portion serving as a lipophilic group and a polyhydric alcohol portion serving as a hydrophilic group.
  • the number of fatty acid ester groups per molecule of polyglycerol fatty acid ester is usually 1 or more.
  • the number of hydroxyl groups derived from glycerin should be 1 or more.
  • the degree of polymerization of glycerin in the polyglycerin fatty acid ester and the type and number of fatty acid ester groups can be arbitrarily combined with those described above. More specifically, the alcohol component of the polyglycerin fatty acid ester can be diglycerin, triglycerin, tetraglycerin, pentaglycerin, hexaglycerin, heptaglycerin, octaglycerin, nonaglycerin, or decaglycerin.
  • the acid component of the polyglycerol fatty acid ester can be a fatty acid such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, or ⁇ -linolenic acid.
  • the polyglycerin fatty acid ester may be a monoester, diester, triester, tetraester, pentaester, or the like.
  • one type may be used alone, or two or more types may be used in combination at any ratio.
  • the polyglycerin fatty acid ester is preferably one or more selected from diglycerin mono-fatty acid ester and decaglycerin fatty acid ester from the viewpoint of good flavor and workability during production.
  • the diglycerin monofatty acid ester is preferably selected from the group consisting of diglycerin monolaurate, diglycerin monomyristate, diglycerin monopalmitate, diglycerin monostearate and diglycerin monooleate. Oleate is more preferred.
  • the decaglycerin fatty acid ester is preferably selected from the group consisting of decaglycerin laurate, decaglycerin myristate, decaglycerin palmitate, decaglycerin stearate and decaglycerin oleate, and decaglycerin monolaurate, decaglycerin mono More preferably, it is selected from the group consisting of myristate, decaglycerin monopalmitate, decaglycerin monostearate and decaglycerin monooleate.
  • the content of the polyglycerol fatty acid ester in the composition is not limited, but from the viewpoint of obtaining a good flavor and improving the production efficiency. Therefore, it is usually 0.1% by weight or more, preferably 0.2% by weight or more, more preferably 0.3% by weight or more, further preferably 0.5% by weight or more.
  • the content of the polyglycerin fatty acid ester is usually 20.0% by weight or less, preferably 15.0% by weight or less, from the viewpoint of imparting an appropriate viscosity to the composition, and 10.0% by weight or less. It is more preferably 8.0% by weight or less, more preferably 8.0% by weight or less.
  • the HLB value of the polyglycerin fatty acid ester is not limited, but is usually 6.0 or more, preferably 7.0 or more, and usually 20.0 or less, preferably from the viewpoint of obtaining good flavor and improving production efficiency. It is 18.0 or less, more preferably 16.0 or less.
  • the composition preferably contains a release agent.
  • the release agent is such that when the composition is manufactured, the components adhere to a manufacturing device such as a mixer or kneader, or when the composition is filled into an exterior material such as a pouch, the components may adhere to a filling machine or the like. Problems such as adhesion can be reduced, and manufacturing efficiency can be improved.
  • the release agent can reduce adhesion between materials constituting the composition to suppress caking (aggregation and solidification between the materials), and can also suppress stickiness of the composition.
  • the oral product containing the composition is improved in appearance, feeling of use such as mouthfeel, flavor, and the like.
  • the composition can be prevented from leaking out of the exterior material, and the properties of the oral product can be improved.
  • Mold release agents include, for example, compounds such as particulate silicon dioxide, magnesium oxide, calcium silicate, magnesium silicate, calcium phosphate, calcium stearate, and magnesium stearate.
  • silicon dioxide is preferred as the release agent because it has a high effect and little influence on flavor.
  • One release agent may be used alone, or two or more release agents may be used in combination at any ratio.
  • the release agent is preferably particulate.
  • the average particle diameter of the particles is usually 20.0 ⁇ m or less, preferably 15.0 ⁇ m or less, more preferably 10.0 ⁇ m or less, and usually 0.2 ⁇ m. That is, it is preferably 0.3 ⁇ m or more, more preferably 0.4 ⁇ m or more, and even more preferably 1.0 ⁇ m or more.
  • the average particle size of the release agent particles means the particle size (D50) at 50% volume-based cumulative volume distribution in the particle size distribution determined by laser diffraction particle size distribution measurement.
  • a general-purpose device such as "Mastersizer 3000" manufactured by Malvern Panalytical can be used for laser diffraction particle size distribution measurement.
  • silicon dioxide having such an average particle diameter may be referred to as "fine silicon dioxide”.
  • the content of the release agent in the composition is not limited, but ensures good flavor and sufficiently exhibits the above effects. From the viewpoint of , preferably 2.5% by weight or less, more preferably 2.0% by weight or less.
  • Water The content of water (water content) in the composition is usually 5% by weight or more from the viewpoint of ease of production of the composition. Furthermore, the lower limit of the water content is preferably 30% by weight or more, more preferably 45% by weight or more, from the viewpoint of improving production efficiency of the composition, improving caking resistance, suppressing stickiness, etc.
  • the upper limit is usually 60% by weight or less, preferably 50% by weight or less. Also, the water content may be 40% by weight or less, 30% by weight or less, or 20% by weight or less.
  • the water content can be adjusted by adjusting the amount of water to be added or by providing heat treatment or drying treatment in the production stage.
  • the water content of the composition is adjusted accordingly depending on the product type (moist or dry). For example, in the case of moist type, the water content is usually 20 to 60% by weight, preferably 30 to 50% by weight. On the other hand, in the dry type, the water content is usually 5-20% by weight, preferably 10-15% by weight.
  • the water content (moisture content) of the composition can be measured using a heat drying moisture meter (for example, HB 43-S manufactured by METER TOLEDO). At the time of measurement, the sample is placed in a predetermined container and heated to reach a temperature of 100°C. The measurement is terminated when the amount of change becomes 1 mg or less in 60 seconds, and the moisture content is calculated from the weighed values before and after heating.
  • a heat drying moisture meter for example, HB 43-S manufactured by METER TOLEDO.
  • the composition may contain substances other than those mentioned above.
  • Other substances include, for example, flavors, pH adjusters, sweeteners (excluding sugar alcohols), humectants, bitterness inhibitors, whitening agents (excluding silicon dioxide), and emulsifiers (excluding polyglycerin fatty acid esters). is mentioned.
  • the content of the substance is not limited, and the composition can be appropriately adjusted according to the product design.
  • Fragrances Flavors are not limited, and examples include menthol, leaf tobacco extract, natural plant flavors (e.g., cinnamon, sage, herbs, chamomile, kudzu grass, sweet tea, cloves, lavender, cardamom, clove, nutmeg, bergamot, geranium). , Honey Essence, Rose Oil, Lemon, Orange, Cinnamon, Caraway, Jasmine, Ginger, Coriander, Vanilla Extract, Spearmint, Peppermint, Cassia, Coffee, Celery, Cascarilla, Sandalwood, Cocoa, Ylang Ylang, Fennel, Anise, licorice, St.
  • natural plant flavors e.g., cinnamon, sage, herbs, chamomile, kudzu grass, sweet tea, cloves, lavender, cardamom, clove, nutmeg, bergamot, geranium.
  • John's bread, plum extract, peach extract, etc. sugars (e.g., glucose, fructose, isomerized sugar, caramel, honey, molasses, etc.), cocoa (powder, extract, etc.), esters (e.g., isoamyl acetate) , linalyl acetate, isoamyl propionate, linalyl butyrate, etc.), ketones (e.g., menthone, ionone, damascenone, ethyl maltol, etc.), alcohols (e.g., geraniol, linalool, anethole, eugenol, etc.), aldehydes (e.g., vanillin , benzaldehyde, anisaldehyde, etc.), lactones (e.g., ⁇ -undecalactone, ⁇ -nonalactone, etc.), animal fragrances (e.g., musk
  • the pH adjuster is not limited, and examples thereof include sodium carbonate, sodium hydrogen carbonate, potassium carbonate, potassium hydrogen carbonate, potassium phosphate, anhydrous sodium phosphate, sodium dihydrogen phosphate, and sodium citrate. mentioned. Among them, sodium carbonate, potassium carbonate, or sodium dihydrogen phosphate is preferable from the viewpoint of influence on the taste of the product. As a pH adjuster, one type may be used alone, or two or more types may be used together in an arbitrary ratio.
  • Sweeteners include, but are not limited to, sugar alcohols such as xylitol, maltitol, erythritol; and acesulfame potassium, sucralose, aspartame, and the like. Sugar alcohols are preferred from the viewpoint of taste control.
  • One type of sweetener may be used alone, or two or more types may be used in combination at any ratio.
  • Bitterness inhibitors are not limited, but include, for example, soybean lecithin. Soybean lecithin is a phospholipid, specifically phosphatidylcholine, phosphatidylethanolamine, phosphatidic acid, and the like. As bitterness inhibitors, one type may be used alone, or two or more types may be used in combination at an arbitrary ratio.
  • Moisturizers are not limited, but examples thereof include polyhydric alcohols such as glycerin and propylene glycol. Glycerin is preferred from the viewpoint of product storage stability. As a moisturizing agent, one kind may be used alone, or two or more kinds may be used together in an arbitrary ratio.
  • the whitening agent is not limited, but examples thereof include fine silicon dioxide, titanium dioxide, calcium carbonate, and the like. From the point of view of the taste impact on the product, finely divided silicon dioxide is preferred. As the whitening agent, one kind may be used alone, or two or more kinds may be used together in an arbitrary ratio.
  • Emulsifiers are not limited, but include, for example, emulsifiers added to foods.
  • emulsifiers include one or more selected from the group consisting of sucrose fatty acid esters, organic acid glycerin fatty acid esters, polyglycerin fatty acid esters and lecithin.
  • Sucrose fatty acid esters include sucrose palmitate and sucrose stearate.
  • the organic acid glycerol fatty acid ester include succinic acid glycerol fatty acid ester and diacetyltartaric acid glycerol fatty acid ester.
  • polyglycerin fatty acid esters examples include decaglycerin fatty acid esters.
  • the content of the emulsifier in the composition is preferably such that the total content of the polyglycerol fatty acid ester and the polyglycerol fatty acid ester is within the above range.
  • Gelling Agents and Gelling Aids As gelling agents, polysaccharides having carboxyl groups are preferred, such as carrageenan, pectin, gum arabic, xanthan, gellan, gum tragacanth, or alginic acid. Furthermore, carrageenan, pectin, gellan, or alginic acid is preferable from the viewpoints that gelation is likely to occur in the presence of calcium ions and that a junction zone can be formed between carboxyl groups and cations to form a crosslinked structure. Among these, LM pectin is preferred for reasons described later. One of these may be used alone, or two or more of them may be used in combination at any ratio.
  • the gelling aid component examples include calcium ions, and the source thereof (gelling aid) is not limited, but examples include calcium halides (chlorides, etc.), citric acid, carbonate, sulfuric acid, and the like. salts, phosphates, lactates, and the like.
  • calcium lactate, calcium carbonate, or calcium phosphate is preferable, and calcium lactate is particularly preferable, from the viewpoints of little influence on taste, high solubility, and pH after dissolution.
  • One of these may be used alone, or two or more of them may be used in combination at any ratio.
  • Gelation aids other than calcium ions include, for example, metal ions such as magnesium, silver, zinc, copper, gold, and aluminum that can bind gelling agents with ionic bonds in the same manner as calcium ions, and cationic Examples include ions of macromolecules. Sources of these (other gelling aids) include, for example, halides (chlorides, etc.) of these metal ions, citric acid, carbonates, sulfates, phosphates, cationic polymers, and the like. are mentioned. One of these may be used alone, or two or more of them may be used in combination at any ratio.
  • Fluidity The fluidity of the composition allows evaluation of the viscosity, adhesion to production equipment, caking resistance, and stickiness of the composition.
  • the fluidity is evaluated by relatively comparing shear stress values at a measurement temperature of 22° C. and a normal stress of 5.0 kPa.
  • the normal stress of 5.0 kPa is a pressure load assumed to be applied to the composition by its own weight during manufacturing, transportation, storage, etc., as a condition that may cause adhesion, caking, and stickiness of the composition to the manufacturing apparatus. be.
  • the shear stress is preferably 4.15 kPa or more, more preferably 4.20 kPa or more, still more preferably 4.25 kPa or more, and preferably 5.85 kPa or less, more preferably 5.80 kPa or less.
  • the shear stress of the composition at the above normal stress of 5.0 kPa can be measured using a rheometer.
  • a rheometer For example, when powder rheometer FT4 manufactured by Freeman Technology Co., Ltd. is used as the rheometer, measurement is performed under the following measurement conditions.
  • ⁇ Measurement mode standard program (25mm_shear_9kPa) ⁇ Measurement temperature: 22°C ⁇ Measurement humidity: 60% RH ⁇ Measurement container: Cylindrical container with an inner diameter of 25 mm and a volume of 10 ml ⁇ Vertical load: 3 to 9 kPa Each raw material to be measured is passed through a sieve (1.18 mm mesh size) to make fine and uniform particles, which is used as a measurement sample, and the measurement is performed according to the procedure of the rheometer described above.
  • the composition is preferably composed of a plurality of solid particles, but the size of the particles is not limited.
  • the dried composition is usually passed through a sieve having a 15 mm mesh ( ⁇ 15 mm) size in terms of user mouthfeel, ease of handling during manufacturing, and control of quality variability.
  • the maximum particle size of the composition when dried is 3.2 mm or less. show.
  • it is not necessary to set the lower limit of the particle size of the dry composition it is usually 3 ⁇ m or more from the viewpoint of preventing leakage from the pouch.
  • the method for preparing the above dried composition is not limited as long as the water content can be reduced to 5% by weight or less.
  • a method of preparing by allowing to stand can be mentioned.
  • the maximum particle size of the composition can be appropriately adjusted, for example, by adjusting the particle size of the nicotine-supported ion exchange resin, the moisture content, and the like.
  • the pH of the composition is not limited, it is usually 7.0 or higher, preferably 7.5 or higher, more preferably 8.0 or higher, from the viewpoint of influence on taste. It is 10.0 or less, preferably 9.5 or less, more preferably 9.0 or less.
  • the pH is a measured value at 25°C.
  • the pH of the composition at a measurement temperature of 25° C. was measured using a pH analyzer (for example, LAQUA F-72 flat ISFET pH electrode manufactured by Horiba Ltd.). It can be measured by measuring the supernatant.
  • a pH analyzer for example, LAQUA F-72 flat ISFET pH electrode manufactured by Horiba Ltd.
  • phthalic acid pH standard solution pH 4.01
  • neutral phosphate pH standard solution pH 6.86
  • borate pH standard solution pH 9.18
  • Oral products are products shaped so that the composition can be contained in the mouth.
  • the product form can be as known. Examples include chewing tobacco, pouches, tablets, gums, films, and liquid forms.
  • a chewing tobacco product is a product in which the nicotine contained in the composition is mixed with saliva and ingested by chewing.
  • Pouch products include a composition (also referred to as a main material or filler) within a sealed water-insoluble exterior material (also referred to as a pouch), and saliva permeates through the pouch and is contained within the pouch. It is a product that can dissolve the ingredients of the product and then pass through the pouch and be carried into the oral cavity.
  • a tablet product refers to a product that is slowly dissolved or disintegrated in the mouth and the components of the composition are ingested from the oral cavity, pharynx, or the like. Tablet products include types such as troches, chewables, or drops.
  • the term "gum product” refers to a product in which the ingredients contained in the composition are mixed with saliva and absorbed through the oral mucosa by chewing by the user. Gum products include types such as chewable gum or bubble gum.
  • a film product refers to a product that adheres to the oral mucosa due to moisture such as saliva when applied to the oral cavity. Ingredients contained in the composition are ingested through the mucous membrane.
  • a liquid product refers to a product that is applied to the oral cavity by spraying or dripping and ingests the ingredients in the composition through the oral mucosa.
  • the main material is preferably the above composition.
  • the indigestible dextrin which is the component (B)
  • the main material may be the above composition or a composition similar thereto, but the total amount of component (B) is 3 to 9 g per product or 0.5 to 1 g per product. Adjusted for quantity.
  • the oral product of the present invention contains an amount of indigestible dextrin (B) of 3 to 9 g per product (first oral product).
  • the average amount of carbohydrates per meal is about 116 g.
  • the amount of component (B) is 3.6-8.1 g for an average carbohydrate amount of 116 g. Therefore, the first oral product containing indigestible dextrin (B) in an amount of 3 to 9 g per product is 3 g per 100 parts by weight of glucose if one product is used during or after ingestion of glucose. It becomes possible to ingest ⁇ 7 parts by weight of component (B). Since the first oral product weighs 3g or more per piece, tablet or gum form is particularly suitable.
  • the oral product of the present invention contains indigestible dextrin (B) in an amount of 0.5 to 1 g per product (second oral product).
  • second oral product contains indigestible dextrin (B) in an amount of 0.5 to 1 g per product (second oral product).
  • the amount of component (B) is 3.6-8.1 g for an average carbohydrate amount of 116 g. Therefore, a second oral product containing indigestible dextrin (B) in an amount of 0.5-1 g per product can be used for 100 wt. It is possible to take 3 to 7 parts by weight of component (B) per part.
  • the second oral product is a double or quadruple type in which one product is continuously connected, it is highly convenient to use. Therefore, the second oral product is particularly suitable in the form of a pouch, which is easy to use as a multi-slot type. Since the second oral product is particularly preferable in the present invention, the product will be described below as an example.
  • the second oral product is also called an oral pouch product.
  • An oral pouch product comprises a main material (also called a filler) and an exterior material (also called a pouch) for packaging the main material.
  • Pouch Pouches are not limited to known ones, as long as they can pack a filling, do not dissolve in water, and can permeate liquids (water, saliva, etc.) and water-soluble components in the filling. can be used.
  • Materials for the pouch include, for example, cellulose-based nonwoven fabrics, and commercially available nonwoven fabrics may be used.
  • a pouch product can be produced by forming a sheet made of such a material into a bag shape, filling the bag with a filler, and sealing the bag by means of heat sealing or the like.
  • the basis weight of the sheet is not particularly limited, and is usually 12 gsm or more and 54 gsm or less, preferably 24 gsm or more and 30 gsm or less.
  • the thickness of the sheet is not particularly limited, and is usually 100 ⁇ m or more and 300 ⁇ m or less, preferably 175 ⁇ m or more and 215 ⁇ m or less.
  • At least one of the inner and outer surfaces of the pouch may be partially coated with a water-repellent material.
  • a water-repellent fluorine-based resin is suitable as the water-repellent material.
  • this type of water-repellent fluorine-based resin includes Asahi Guard (registered trademark) manufactured by Asahi Glass Co., Ltd.
  • Water-repellent fluorine-based resins are applied to packaging materials for foods and products containing oils and fats, such as confectionery, dairy products, side dishes, fast food, and pet food. Therefore, this type of water-repellent fluororesin is safe even when applied to pouches placed in the oral cavity.
  • the water-repellent material is not limited to the fluorine-based resin, and may be, for example, a material having a water-repellent action such as a paraffin resin, a silicon-based resin, or an epoxy-based resin.
  • the pouch can contain indigestible dextrin (component (B)).
  • component (B) indigestible dextrin
  • a pouch containing component (B) can be prepared by coating, spraying, or impregnating a pouch with a dispersion in which component (B) is dispersed.
  • the pouch may also contain optional ingredients. Examples of such components include raw materials that adjust aroma and taste, flavors, additives, tobacco extracts, pigments, and the like.
  • the manner in which these components are contained is not limited, and examples thereof include the manner in which they are applied to the surface of the pouch, the manner in which they are impregnated, and the manner in which they are contained in the fibers when they are made of fibers.
  • the appearance of the pouch is also not limited. Pouches may be non-transparent, translucent, or transparent. The filling can be seen through if the pouch is translucent or transparent.
  • the size of oral pouch products is not limited.
  • the size of the product before use may have a lower long dimension of 25 mm or greater, 28 mm or greater, 35 mm or greater, or 38 mm or greater.
  • the upper limit may be 40 mm or less.
  • the lower limit of the short side may be 10 mm or more or 14 mm or more.
  • the upper limit may be 20 mm or less or 18 mm or less.
  • the ratio of the weight of the filler to the total weight of the oral pouch product is not limited, but is usually 80% by weight or more, preferably 85% by weight or more, more preferably 90% by weight or more, and It is usually 99% by weight or less, preferably 97% by weight or less, more preferably 95% by weight or less.
  • the amount of filling per oral pouch product is preferably 0.5 mg to 25 mg.
  • Oral pouch products can contain component (B) in the outer packaging, filler, or both.
  • the final amount of component (B) is the desired amount (0.5 to 1 g per product for oral pouch products, the same for other products ) is adjusted to be
  • Production method Production of oral product composition It is preferably produced through a step of mixing a base material, sugar alcohol, polyglycerin fatty acid ester, and a release agent. Mixing can be accomplished by placing all ingredients in a mixer and mixing.
  • nicotine component (A)
  • indigestible dextrin component (B)
  • base material sugar alcohol, release agent, and optionally water and other substances (sweetener, flavor , moisturizing agent, etc.)
  • sweetener, flavor , moisturizing agent, etc. a substance that is sweetened by the user
  • the order of mixing each raw material is not limited, and they may be put into a mixer in any order or at the same time and mixed, or after uniformly mixing the solid raw materials, the liquid raw materials may be added and further mixed. good. From the viewpoint of workability, the latter mode is preferred.
  • the polyglycerin fatty acid ester solution is sprayed onto the first mixture to mix the first mixture and the polyglycerin fatty acid ester to obtain a second mixture. Since the polyglycerol fatty acid ester exerts an anti-caking effect, caking is less likely to occur in subsequent steps.
  • the solvent for the polyglycerin fatty acid ester solution is not limited as long as it can dissolve the polyglycerin fatty acid ester, but alcoholic solvents such as ethanol are preferred. In order not to leave a large amount of the solvent of the polyglycerin fatty acid ester solution in the second mixture, heat treatment may be performed during or after spraying the polyglycerin fatty acid ester solution to the first mixture.
  • a process of drying the second mixture may be performed (drying step). After that, a cooling process may be performed. Cooling may be natural cooling, or may be performed using some cooling means (cooling step). Drying can be used to adjust the moisture content of the second mixture to a desired value, for example between 5 and 60% by weight. This facilitates adjustment of the moisture content in the composition.
  • an aqueous solution containing a pH adjuster, a sweetener such as acesulfame potassium, a flavoring agent such as menthol, a bitterness inhibitor such as soybean lecithin, or a humectant such as glycerin is added (addition agent addition step).
  • the above additives may be added as solids or as an aqueous solution dissolved in water. When added in the form of an aqueous solution, it may be dissolved in a predetermined amount of water in advance and added so as to achieve the final moisture content of the oral product.
  • composition can be processed by a known method to produce oral products.
  • the oral pouch product will be described below as an example.
  • An oral pouch product can be manufactured by packaging the composition with an exterior material (packaging process).
  • the packaging method is not limited, and known methods can be applied.
  • a known method can be used, such as a method in which the composition is put into a bag-shaped nonwoven fabric and then sealed.
  • additional water may be added as desired after sealing (water addition step). For example, if the water content of the final composition is 50% by weight and the water content of the filled composition is 15% by weight, the remaining 35% by weight of water is added.
  • the product is used so that 3-7 parts by weight of the indigestible dextrin is ingested per 100 parts by weight of glucose during or after ingestion of glucose. Specifically, the product is used by placing it in the mouth during or after ingestion of glucose. Indigestible dextrin is expected to have the effect of suppressing blood sugar levels. For example, since many people enjoy smoking after meals, the oral product of the present invention is preferably used after meals. Postprandial refers in one aspect to 0 to 30 minutes after the end of a meal.
  • each characteristic in the present invention is carried out by holding the measurement sample in the same environment as the environment to be measured for 48 hours or more before measurement.
  • the temperature, humidity, and pressure to be measured are normal temperature (25 ⁇ 2° C.), normal humidity (60 ⁇ 5% RH), and normal pressure (atmospheric pressure).
  • Example 1 The following ingredients are mixed in a mixer to produce an oral product composition. Nicotine 2 parts by weight Indigestible dextrin 800 parts by weight Pectin 2.1 parts by weight Maltitol 37.8 parts by weight Cellulose 22.7 parts by weight Sodium phosphate 14.3 parts by weight Polyglycerin fatty acid ester 10.3 parts by weight Silica 2.1 parts by weight Parts by weight Acesulfame K 0.3 parts by weight
  • Example 2 0.7 g of the composition obtained in Example 1 is collected and packed in a known pouch to produce an oral pouch product.
  • the nicotine content per one product is 1.6 mg, and the amount of indigestible dextrin is 0.65 g.

Abstract

Provided is an oral product composition that contains nicotine or a nicotine-containing raw material (A) and indigestible dextrin (B), and during or after the ingestion of glucose, 3-7 parts by weight of the indigestible dextrin can be absorbed per 100 parts by weight of the glucose.

Description

難消化デキストリンを含有するオーラル製品および当該製品用組成物Oral product containing indigestible dextrin and composition for such product
 本発明は、難消化デキストリンを含有するオーラル組成物および当該製品用組成物に関する。 The present invention relates to oral compositions containing indigestible dextrin and compositions for such products.
 II型糖尿病は代表的な成人病であり、その予防策として血糖値の急激な上昇を抑制することが重要であることが知られている。特に、食事後に難消化デキストリンを摂取すると、血糖値の急激な上昇が抑えられることが知られている。例えば、非特許文献1には、難消化デキストリンを配合した飲料によって、食後血糖値の上昇が抑制できることが開示されている。 Type II diabetes is a typical adult disease, and it is known that it is important to prevent a rapid increase in blood sugar levels as a preventive measure. In particular, it is known that ingestion of indigestible dextrin after a meal suppresses a rapid increase in blood sugar level. For example, Non-Patent Document 1 discloses that a beverage containing indigestible dextrin can suppress the increase in postprandial blood glucose level.
 ところで、特許文献1に開示されているとおり、スヌースのようなオーラルたばこ製品が知られている。使用者は当該製品を口腔内に入れて使用する。 By the way, as disclosed in Patent Document 1, oral tobacco products such as snus are known. A user puts the product in the oral cavity and uses it.
国際公開2012/133365号WO2012/133365
 発明者らは、前記飲料以外の形態の製品において難消化デキストリンを摂取することができれば、より使用者の利便性を高められるとの着想を得た。かかる事情に鑑み、本発明は、難消化デキストリンを含有する新規形態の製品を提供することを課題とする。 The inventors came up with the idea that if the indigestible dextrin could be ingested in a product other than the beverage, it would be more convenient for the user. In view of such circumstances, an object of the present invention is to provide a novel form of product containing indigestible dextrin.
 発明者らは、難消化デキストリンを含有するオーラル製品によって、前記課題を解決できることを見出した。
態様1
 ニコチンまたはニコチン含有原料(A)と、難消化デキストリン(B)と、を含み、
 グルコース摂取中または摂取後に、当該グルコース100重量部に対し、3~7重量部の前記難消化デキストリンを摂取できるオーラル製品用組成物。
態様2
 態様1に記載の組成物を含有するオーラル製品であって、当該製品当たりの前記難消化デキストリン(B)の重量が3~9gである、オーラル製品。
態様3
 態様1に記載の組成物を含有するオーラル製品であって、当該製品当たりの前記難消化デキストリン(B)の重量が0.5~1gである、オーラル製品。
態様4
 ニコチンまたはニコチン含有原料(A)を含む主材と、
 当該主材の外側に設けられた外装材と、を備え、
 前記外装材または前記主材が難消化デキストリン(B)をさらに含有し、
 前記難消化デキストリン(B)の量が当該製品中3~9gである、
オーラル製品。
態様5
 ニコチンまたはニコチン含有原料(A)を含む主材と、
 当該主材の外側に設けられた外装材と、を備え、
 前記外装材または前記充填物が難消化デキストリン(B)をさらに含有し、
 前記難消化デキストリン(B)の量が当該製品中0.5~1gである、
オーラル製品。
態様6
 噛みたばこ、パウチ、錠剤、ガム、フィルム、または液体の形態である、態様2または3に記載のオーラル製品。
態様7
 ガムまたは錠剤の形態である、態様2または4に記載のオーラル製品。
態様8
 パウチの形態である、態様3または5に記載のオーラル製品。
態様9
 態様2~8のいずれかに記載の製品の摂取方法であって、
 グルコースの摂取中または摂取後に、当該グルコース100重量部に対し、3~7重量部の前記難消化デキストリンを摂取する、摂取方法。
The inventors have found that the above problems can be solved by an oral product containing indigestible dextrin.
Aspect 1
nicotine or a nicotine-containing raw material (A) and an indigestible dextrin (B),
A composition for oral products, in which 3 to 7 parts by weight of the indigestible dextrin can be ingested with respect to 100 parts by weight of the glucose during or after the ingestion of glucose.
Aspect 2
An oral product containing the composition according to aspect 1, wherein the weight of the indigestible dextrin (B) per product is 3-9 g.
Aspect 3
An oral product containing the composition according to aspect 1, wherein the weight of the indigestible dextrin (B) per product is 0.5-1 g.
Aspect 4
a main material containing nicotine or a nicotine-containing raw material (A);
and an exterior material provided outside the main material,
The exterior material or the main material further contains indigestible dextrin (B),
The amount of the indigestible dextrin (B) is 3 to 9 g in the product,
oral products.
Aspect 5
a main material containing nicotine or a nicotine-containing raw material (A);
and an exterior material provided outside the main material,
The exterior material or the filling further contains a non-digestible dextrin (B),
The amount of the indigestible dextrin (B) is 0.5 to 1 g in the product,
oral products.
Aspect 6
4. An oral product according to aspects 2 or 3 in the form of chewing tobacco, pouches, tablets, gums, films, or liquids.
Aspect 7
An oral product according to aspect 2 or 4 in the form of a gum or tablet.
Aspect 8
An oral product according to aspect 3 or 5, which is in the form of a pouch.
Aspect 9
A method of ingesting a product according to any of aspects 2-8, comprising:
A method of ingestion, comprising ingesting 3 to 7 parts by weight of the indigestible dextrin with respect to 100 parts by weight of the glucose during or after the ingestion of glucose.
 本発明によって難消化デキストリンを含有する新規形態の製品を提供できる。 A new form of product containing indigestible dextrin can be provided by the present invention.
 以下に本発明を詳細に説明する。本発明において「X~Y」はその端値であるXとYを含む。オーラル製品とは、口腔に製品を含んだ状態で、唾液を介し有効成分を口腔粘膜より摂取する製品である。オーラル製品は、使用時に燃焼やデバイスによる加熱や霧化を伴わない。 The present invention will be described in detail below. In the present invention, "X to Y" includes X and Y which are the end values. Oral products are products in which active ingredients are ingested through the oral mucosa via saliva while the product is contained in the oral cavity. Oral products do not involve burning or heating or atomization by devices when used.
1.オーラル製品用組成物
 オーラル製品用組成物(以下単に「組成物」ともいう)は、成分(A)としてニコチンまたはニコチン含有原料と、成分(B)として難消化デキストリンを含む。
1. Composition for Oral Products The composition for oral products (hereinafter also simply referred to as "composition") contains nicotine or a nicotine-containing raw material as component (A) and indigestible dextrin as component (B).
(1)成分(A)
 オーラル製品用組成物は、成分(A)としてニコチンまたはニコチン含有原料を含有する。例えば、当該化合物は化合物としてのニコチンを含有してもよく、ニコチン塩や安定化させたニコチン等のニコチン含有原料を含有してもよい。
(1) Component (A)
Compositions for oral products contain nicotine or nicotine-containing raw materials as component (A). For example, the compound may contain nicotine as a compound, or nicotine-containing raw materials such as nicotine salts and stabilized nicotine.
 安定化させたニコチンとしては、例えばイオン交換樹脂に担持させたニコチン等のニコチン担持物質が挙げられる。イオン交換樹脂として、弱酸性陽イオン交換樹脂を挙げることができる。ニコチンが担持されたイオン交換樹脂として、具体的にニコチンポラクリレックスと呼ばれる、例えば10重量%以上、20重量%以下のニコチンを含有する樹脂複合体を用いることができる。ニコチンポラクリレックスで用いられるイオン交換樹脂は弱酸性陽イオン交換樹脂である。ニコチンポラクリレックスを用いる場合、前記組成物に対する添加量は、通常0.5重量%以上であり、1.0重量%以上であることが好ましく、2.0重量%以上であることがより好ましい。一方、風味の観点から、前記組成物に対するニコチンポラクリレックスの添加量は、通常15.0重量%以下であり、12.0重量%以下であることが好ましく、10.0重量%以下であることがより好ましい。 Examples of stabilized nicotine include nicotine-carrying substances such as nicotine carried on ion-exchange resins. Examples of ion exchange resins include weakly acidic cation exchange resins. As the nicotine-supported ion exchange resin, a resin complex containing nicotine in an amount of 10% by weight or more and 20% by weight or less, specifically called nicotine polacrilex, can be used. The ion exchange resin used in nicotine polacrilex is a weakly acidic cation exchange resin. When nicotine polacrilex is used, the amount added to the composition is usually 0.5% by weight or more, preferably 1.0% by weight or more, and more preferably 2.0% by weight or more. . On the other hand, from the viewpoint of flavor, the amount of nicotine polacrilex added to the composition is usually 15.0% by weight or less, preferably 12.0% by weight or less, and 10.0% by weight or less. is more preferable.
 また、ニコチン含有原料は、例えばたばこ葉を粉砕したたばこ粉末を含むたばこ材料であってもよい。たばこ粉末は、乾燥したたばこ葉のラミナの刻み、微粉、または繊維等を含んでもよく、例えば後述する方法によって調製される。本発明において、たばこ葉は、葉肉(ラミナ)、葉脈(ステム)、または根を含んでもよい。前記たばこ材料は、基本的にたばこ葉のラミナから得られるたばこ粉末の他に、たばこ葉の中骨や根に由来する要素を含んでいてもよい。 In addition, the nicotine-containing raw material may be a tobacco material containing, for example, tobacco powder obtained by pulverizing tobacco leaves. Tobacco powder may include dried tobacco leaf lamina cuts, fines, or fibers, and is prepared, for example, by the method described below. In the present invention, tobacco leaves may include mesophyll (lamina), veins (stem), or roots. The tobacco material may contain tobacco powder, which is basically obtained from tobacco leaf lamina, as well as elements derived from tobacco leaf backbones and roots.
 たばこ粉末の粒径は限定されないが、口腔内でのなじみを良好にして使用感を高めることと、たばこ粉末に含まれる香味成分の口腔内への放出を良好にする観点から、1.2mmのメッシュを通過したものであることが好ましく、1.0mmのメッシュを通過したものであることがより好ましい。 The particle size of the tobacco powder is not limited, but from the viewpoint of improving the familiarity in the oral cavity and enhancing the feeling of use, and from the viewpoint of improving the release of the flavoring ingredients contained in the tobacco powder into the oral cavity, it is recommended to use a particle size of 1.2 mm. It is preferably one that has passed through a mesh, and more preferably one that has passed through a 1.0 mm mesh.
 たばこ粉末の原料となるたばこ種は特に限定されず、例えばニコチアナ属であり、ニコチアナ・タバカムの黄色種、およびバーレー種、ニコチアナ・ルスチカのブラジリア種などを例示できる。後述するたばこ材料およびたばこ葉についてもこれらと同じ種を使用できる。 The tobacco species used as the raw material for the tobacco powder is not particularly limited, and examples thereof include Nicotiana tabacum yellow variety, Burley variety, and Nicotiana rustica Brasilia variety. The same species can be used for tobacco materials and tobacco leaves, which will be described later.
 たばこ粉末は以下のようにして調製されることが好ましい。まず、たばこ葉を粉砕して得たたばこ粉末に対して、塩基を添加して混合する。添加する塩基としては炭酸カリウムおよび炭酸ナトリウムを挙げることでき、水溶液として添加することが好ましい。また、例えばオーラルパウチ製品製造時のニコチン安定化のため、リン酸二水素ナトリウムのようなpH調整剤を添加してもよい。塩基の添加後の混合物のpHは8.0~9.0に調整されることが好ましい。この混合物における、たばこ粉末の含有率は、60~90重量%であることが好ましい。 "Tobacco powder is preferably prepared as follows." First, a base is added to and mixed with tobacco powder obtained by pulverizing tobacco leaves. Examples of the base to be added include potassium carbonate and sodium carbonate, which are preferably added as an aqueous solution. Also, a pH adjuster such as sodium dihydrogen phosphate may be added, for example, to stabilize nicotine during the production of oral pouch products. The pH of the mixture after addition of the base is preferably adjusted to 8.0-9.0. The content of tobacco powder in this mixture is preferably 60 to 90% by weight.
 塩基を添加した後、例えば品温が65~90℃、好ましくは品温が70~80℃となる条件で、例えば0.5~3時間、好ましくは0.8~2時間加熱を行う。これにより、たばこ粉末の殺菌が行われる。加熱は、蒸気注入による加熱と、ジャケットによる加熱のどちらか一方または両方により行うことができる。加熱後の混合物のpHは8.0~9.0であることが好ましく、加熱後の混合物の含水率は10~50重量%であることが好ましい。 After adding the base, the mixture is heated, for example, for 0.5 to 3 hours, preferably 0.8 to 2 hours, under conditions such that the product temperature is 65 to 90°C, preferably 70 to 80°C. Thus, the tobacco powder is sterilized. Heating can be accomplished by steam injection heating, jacket heating, or both. The pH of the mixture after heating is preferably 8.0 to 9.0, and the water content of the mixture after heating is preferably 10 to 50% by weight.
 加熱後、得られた処理たばこ粉末に対して必要に応じて蒸気注入を止めてジャケットのみの加熱を行ない、乾燥処理を行う。その後、15~25℃程度で1時間程度、冷却する態様を挙げることができる。 After heating, if necessary, the steam injection is stopped and only the jacket is heated to dry the treated tobacco powder obtained. After that, it can be cooled at about 15 to 25° C. for about 1 hour.
 たばこ粉末を含むたばこ材料を用いる場合、前記組成物に対するその添加量は、通常0.001重量%以上であり、0.01重量%以上であることが好ましく、0.05重量%以上であることがより好ましい。一方、風味の観点から、前記組成物に対するその添加量は、通常90重量%以下であり、好ましくは80重量%以下、70重量%以下、45重量%以下、40重量%以下、または30重量%以下である。 When a tobacco material containing tobacco powder is used, the amount added to the composition is usually 0.001% by weight or more, preferably 0.01% by weight or more, and 0.05% by weight or more. is more preferred. On the other hand, from the viewpoint of flavor, the amount added to the composition is usually 90% by weight or less, preferably 80% by weight or less, 70% by weight or less, 45% by weight or less, 40% by weight or less, or 30% by weight. It is below.
 ニコチン含有原料は、たばこ葉等のニコチン含有物質を抽出することにより得られるニコチン含有抽出液であってもよい。 The nicotine-containing raw material may be a nicotine-containing extract obtained by extracting nicotine-containing substances such as tobacco leaves.
 上記の態様の中でも、的確なニコチンの供給や、取扱い易さの観点から、ニコチン担持物質を用いることが好ましい。また、通常、たばこ粉末を添加した場合、前記組成物やオーラル製品の色がたばこ葉の色となる傾向がある。一方で、無色のニコチン含有化合物を用いた場合、白色の組成物やオーラル製品を提供することが可能となる。白色のオーラル製品を好む使用者にとって、このような態様は利点である。成分(A)として説明した上記の原料は、1種を用いてもよいし、2種以上を併用してもよい。 Among the above embodiments, it is preferable to use a nicotine-carrying substance from the viewpoint of accurate nicotine supply and ease of handling. Moreover, when tobacco powder is added, the composition or oral product generally tends to take on the color of tobacco leaves. On the other hand, when a colorless nicotine-containing compound is used, it is possible to provide white compositions and oral products. Such an aspect is an advantage for users who prefer white oral products. One of the raw materials described above as the component (A) may be used alone, or two or more thereof may be used in combination.
 前記組成物中の総ニコチンの含有率は、限定されないが、ユーザーの嗜好性の観点から、通常0.1~15.0重量%である。したがって成分(A)としてニコチン含有原料を用いる場合は、総ニコチン含有率がこの範囲になるように当該原料の量は調整される。ニコチンがイオンとして存在する場合、上記の含有率は、ニコチンイオンとしての含有率である。前記組成物中のニコチンの含有率は、ガスクロマトグラフィー質量分析計(GC-MS)、液体クロマトグラフィー(LC、UV検出)等で測定することができる。 Although the content of total nicotine in the composition is not limited, it is usually 0.1 to 15.0% by weight from the viewpoint of user's preference. Therefore, when a nicotine-containing raw material is used as component (A), the amount of the raw material is adjusted so that the total nicotine content falls within this range. When nicotine exists as ions, the above content is the content as nicotine ions. The content of nicotine in the composition can be measured by gas chromatography-mass spectrometer (GC-MS), liquid chromatography (LC, UV detection), or the like.
(2)成分(B)
 オーラル製品用組成物は、成分(B)として難消化デキストリンを含む。難消化デキストリンは、1)澱粉に微量の酸を添加して加熱処理して焙焼デキストリンを得て、2)焙焼デキストリンにグルコース間の結合を切断する酵素を作用させ、3)当該処理によってグルコースに分解されなかったデキストリン部分を精製する方法で製造することができる(佐々木朋子、砂糖類・でん紛情報2018.2、p2)。難消化デキストリンは、一態様において平均分子量が2000程度であり、澱粉の加水分解を示す指標であるDE(dextrose equivalent)が20以下程度のデキストリンである。具体的な難消化デキストリンとしては、松谷化学工業株式会社より市販されている「ファイバーソル2」等が挙げられる。
(2) Component (B)
The oral product composition contains indigestible dextrin as component (B). Indigestible dextrin is obtained by 1) adding a trace amount of acid to starch and heat-treating it to obtain roasted dextrin, 2) allowing an enzyme that cleaves the bond between glucose to act on the roasted dextrin, and 3) by the treatment. It can be produced by purifying the dextrin portion that has not been decomposed into glucose (Tomoko Sasaki, Sugar/Starch Information 2018.2, p2). In one aspect, the indigestible dextrin is a dextrin having an average molecular weight of about 2000 and a DE (dextrose equivalent) of about 20 or less, which is an index of starch hydrolysis. Specific examples of indigestible dextrin include "Fibersol 2" commercially available from Matsutani Chemical Industry Co., Ltd., and the like.
 難消化デキストリンは、食物繊維としてその機能を発揮することができる。すなわち、市販の原料製品においては、食物繊維として機能しない成分も存在しうるが、食物繊維として定量される成分が有効成分として働くと理解されている。従って、本発明における用語「難消化デキストリン」とは、食物繊維として機能する難消化デキストリンをいう。例えば市販品等の混合物においては、食物繊維として検出される難消化デキストリンが本発明における「難消化デキストリン」である。食物繊維として機能する難消化デキストリンの主成分は3糖でありうるので、当該難消化デキストリンの平均分子量は一態様において500~2000である。難消化デキストリンの分析方法については別途詳述する。 Indigestible dextrin can exert its function as dietary fiber. That is, it is understood that ingredients that are quantified as dietary fiber work as active ingredients, although ingredients that do not function as dietary fiber may exist in commercially available raw material products. Therefore, the term "indigestible dextrin" in the present invention refers to indigestible dextrin that functions as dietary fiber. For example, in a mixture such as a commercial product, the indigestible dextrin detected as dietary fiber is the "indigestible dextrin" in the present invention. Since the main component of the indigestible dextrin that functions as dietary fiber can be trisaccharide, the average molecular weight of the indigestible dextrin is 500-2000 in one embodiment. A method for analyzing indigestible dextrin will be described in detail separately.
 食物繊維としての難消化デキストリンは上述のように低分子量であるため、酵素-HPLC法によって組成物から比較的簡易に定量することが可能である。難消化デキストリンの分析および定量方法は、適切に分析および定量できる方法であれば限定されず、いかなる方法を用いても当業者は定量することが可能であるが、非制限的に、以下のような各ステップを経る方法が好ましい。 As the indigestible dextrin used as dietary fiber has a low molecular weight as described above, it can be quantified relatively easily from the composition by the enzyme-HPLC method. The method for analyzing and quantifying the indigestible dextrin is not limited as long as it can be appropriately analyzed and quantified, and a person skilled in the art can quantify using any method. A method that goes through each step is preferable.
 試料を溶解後、熱安定α-アミラーゼによって消化する。次に、アミログルコシダーゼによってさらに消化する。必要に応じてプロテアーゼによって、試料中のたんぱく質を分解しておく。その後、エタノールを加えて沈殿を生成させた後、吸引ろ過してろ液と沈殿に分離する。ろ液をロータリーエバポレーターで濃縮した後、イオン交換樹脂により、たんぱく質分解物、有機酸類、および無機塩類等を除去し、高速液体クロマトグラフィー(HPLC)に供する。得られたクロマトグラフ上で食物繊維画分(三糖類以上)と単糖類、二糖類画分とを分け、食物繊維画分とブドウ糖のピーク面積の比率を求める。同時に、内標準物質としてブドウ糖を使用し、ピーク面積比率にブドウ糖重量を掛けることにより低分子水溶性食物繊維量を算出する。原則として、三糖類のひとつであるマルトトリオースのピーク溶出位置を指標とし、これと同じかこれより前に溶出するものを食物繊維画分として定量する。 After dissolving the sample, it is digested with thermostable α-amylase. It is then further digested with amyloglucosidase. If necessary, the protein in the sample is degraded by protease. After that, ethanol is added to generate a precipitate, which is separated into a filtrate and a precipitate by suction filtration. After concentrating the filtrate with a rotary evaporator, protein degradation products, organic acids, inorganic salts and the like are removed with an ion exchange resin, and subjected to high performance liquid chromatography (HPLC). Separate the dietary fiber fraction (trisaccharides or higher) from the monosaccharide and disaccharide fractions on the obtained chromatograph, and determine the peak area ratio of the dietary fiber fraction and glucose. At the same time, using glucose as an internal standard substance, the amount of low-molecular-weight water-soluble dietary fiber is calculated by multiplying the peak area ratio by the weight of glucose. In principle, the peak elution position of maltotriose, one of the trisaccharides, is used as an indicator, and the dietary fiber fraction is quantified by eluting at or before this peak.
 オーラル製品用組成物は、グルコース摂取中または摂取後に、当該グルコース100重量部に対し、3~7重量部の難消化デキストリンを摂取できる量の難消化デキストリンを含有する。 The composition for oral products contains an amount of indigestible dextrin that allows ingestion of 3 to 7 parts by weight of indigestible dextrin per 100 parts by weight of glucose during or after ingestion of glucose.
 下表に示すとおり、グルコース100重量部に対し、3~7重量部の難消化デキストリンは血糖値の上昇を抑制する。表中、成分(B)の量は、食物繊維として機能する難消化デキストリンの量である。 As shown in the table below, 3-7 parts by weight of indigestible dextrin for 100 parts by weight of glucose suppresses the increase in blood sugar level. In the table, the amount of component (B) is the amount of indigestible dextrin that functions as dietary fiber.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
 前記組成物中の成分(B)の含有量は、グルコース100重量部に対し、3~7重量部の成分(B)を摂取できる量であればよい。一態様において、前記組成物中の成分(B)の含有量は、ニコチン1重量部に対して、好ましくは300~700重量部である。 The content of component (B) in the composition should be an amount that allows 3 to 7 parts by weight of component (B) to be ingested per 100 parts by weight of glucose. In one aspect, the content of component (B) in the composition is preferably 300 to 700 parts by weight with respect to 1 part by weight of nicotine.
(3)基材
 前記組成物は、基材を含有することが好ましい。基材は、特に限定されず、水分を吸着および保持できる多糖類または多孔質構造体等が挙げられる。具体的には、基材は、セルロース、微結晶セルロース(MCC)、球状セルロース、および多孔質セルロースからなる群から選択される一種以上であることが好ましい。中でも前記組成物のかさ密度調整の自由度および白色を呈する観点から、セルロースであることがより好ましい。これらの物質は、1種類を単独で用いてもよく、また、2種類以上を任意の比率で併用してもよい。
(3) Substrate The composition preferably contains a substrate. The substrate is not particularly limited, and examples thereof include polysaccharides and porous structures capable of adsorbing and retaining moisture. Specifically, the substrate is preferably one or more selected from the group consisting of cellulose, microcrystalline cellulose (MCC), spherical cellulose, and porous cellulose. Among them, cellulose is more preferable from the viewpoint of flexibility in adjusting the bulk density of the composition and exhibiting white color. One type of these substances may be used alone, or two or more types may be used in combination at any ratio.
 前記組成物中の基材の含有率(基材を2種類以上含有する場合は、それらの総含有率)は、限定されない。しかしながら製造中または製品保管中における水分の溶出を抑制して品質向上を図るという観点、および製品の白色度を高めることで使用者にとって望ましい外観を付与する観点から、前記含有率は、通常10重量%以上であり、15量%以上であることが好ましく、20重量%以上であることがより好ましい。また、前記含有率の上限は限定されないが、その他の原料を配合できる限界の観点から、通常70重量%以下であり、68重量%以下であることが好ましく、65重量%以下であることがより好ましい。 The content of the base material in the composition (the total content when two or more types of base materials are contained) is not limited. However, from the viewpoint of improving quality by suppressing the elution of water during manufacturing or product storage, and from the viewpoint of imparting a desirable appearance to users by increasing the whiteness of the product, the content is usually 10% by weight. % or more, preferably 15% by weight or more, more preferably 20% by weight or more. In addition, although the upper limit of the content is not limited, it is usually 70% by weight or less, preferably 68% by weight or less, more preferably 65% by weight or less, from the viewpoint of the limit that can be blended with other raw materials. preferable.
(4)糖アルコール
 前記組成物は、糖アルコールを含有することが好ましい。糖アルコールの種類は特に限定されず、例えば、キシリトール、マルチトール、エリスリトール、ソルビトール、マンニトール、およびラクチトール等を挙げることができる。これらのうち、良好な風味を付与する観点から、マルチトールが好ましい。これらの物質は、1種類を単独で用いてもよく、また、2種類以上を任意の比率で併用してもよい。
(4) Sugar alcohol The composition preferably contains a sugar alcohol. The type of sugar alcohol is not particularly limited, and examples thereof include xylitol, maltitol, erythritol, sorbitol, mannitol, and lactitol. Among these, maltitol is preferable from the viewpoint of imparting good flavor. One type of these substances may be used alone, or two or more types may be used in combination at any ratio.
 前記組成物中の糖アルコールの含有率(糖アルコールを2種類以上含有する場合は、それらの総含有率)は、限定されないが、風味の調節の観点から、通常1重量%以上であり、5量%以上であることが好ましく、10重量%以上であることがより好ましい。また、その上限は、通常80重量%以下であり、70重量%以下であることが好ましく、60重量%以下であることがより好ましい。 The content of sugar alcohols in the composition (when two or more types of sugar alcohols are contained, the total content of them) is not limited, but from the viewpoint of flavor adjustment, it is usually 1% by weight or more. % or more, and more preferably 10% or more by weight. Moreover, the upper limit is usually 80% by weight or less, preferably 70% by weight or less, and more preferably 60% by weight or less.
(5)ポリグリセリン脂肪酸エステル
 前記組成物は、ポリグリセリン脂肪酸エステルを含有することが好ましい。ポリグリセリン脂肪酸エステルにおけるグリセリンの重合度は2~10であることが好ましい。ポリグリセリン脂肪酸エステルは、乳化剤として機能する。そのため、ポリグリセリン脂肪酸エステルを含有することにより、前記組成物の各成分の均一な混合状態が保持され、香味成分を安定に保つことができるため、当該組成物の香味を良好にすることができる。また、ポリグリセリン脂肪酸エステルは、前記組成物に適度な粘性を付与し、各成分を一体に結着させることができるため、当該組成物のぱさつきを抑え、使用感や、香味等を良好にすることができる。加えて、前記組成物が水の含有量(含水率)の少ないドライタイプの場合でも、当該組成物をパウチ等の外装材に充填する際に、当該組成物が飛散することを抑制できる。このように、前記組成物にポリグリセリン脂肪酸エステルを含有させることで、オーラル製品の製造における作業効率、歩留まり等の製造効率を向上することができる。
(5) Polyglycerin Fatty Acid Ester The composition preferably contains a polyglycerin fatty acid ester. The degree of polymerization of glycerin in the polyglycerol fatty acid ester is preferably 2-10. Polyglycerin fatty acid ester functions as an emulsifier. Therefore, by containing the polyglycerol fatty acid ester, a uniform mixing state of each component of the composition can be maintained, and the flavor component can be kept stable, so that the flavor of the composition can be improved. . In addition, the polyglycerol fatty acid ester imparts an appropriate viscosity to the composition, and can bind each component together, thereby suppressing dryness of the composition and improving the feeling of use, flavor, etc. be able to. In addition, even when the composition is a dry type with a low water content (moisture content), scattering of the composition can be suppressed when filling the composition into an exterior material such as a pouch. Thus, by including the polyglycerol fatty acid ester in the composition, it is possible to improve production efficiency such as work efficiency and yield in the production of oral products.
 ポリグリセリン脂肪酸エステルは、グリセリンの脱水縮合体の脂肪酸エステルであり、グリセリンの重合度は、通常2以上であり、3以上であってもよく、また、通常10以下であり、8以下であってよい。 Polyglycerin fatty acid ester is a fatty acid ester of a dehydration condensate of glycerin, and the degree of polymerization of glycerin is usually 2 or more, may be 3 or more, and is usually 10 or less, and may be 8 or less. good.
 ポリグリセリン脂肪酸エステルの脂肪酸エステル基(RCOO-基)は、脂肪酸に由来する。当該脂肪酸は限定されず、飽和脂肪酸であってもよく、不飽和脂肪酸であってもよい。また、当該脂肪酸の炭素数は、良好な香味および製造効率の観点から、通常10以上であり、12以上であることが好ましく、14以上であることがより好ましく、16以上であることがさらに好ましく、また、通常30以下であり、26以下であることが好ましく、22以下であることがより好ましく、20以下であることがさらに好ましい。当該脂肪酸は、置換基を有していてもよく、無置換であってもよい。 The fatty acid ester group (RCOO- group) of polyglycerin fatty acid ester is derived from fatty acid. The fatty acid is not limited and may be a saturated fatty acid or an unsaturated fatty acid. In addition, the carbon number of the fatty acid is usually 10 or more, preferably 12 or more, more preferably 14 or more, and further preferably 16 or more, from the viewpoint of good flavor and production efficiency. Also, it is usually 30 or less, preferably 26 or less, more preferably 22 or less, and even more preferably 20 or less. The fatty acid may have a substituent or may be unsubstituted.
 また、ポリグリセリン脂肪酸エステル一分子が有する脂肪酸エステル基の数は、ポリグリセリン脂肪酸エステルが乳化剤としての機能を発揮し得る構造であれば限定されず、グリセリンの重合度およびグリセリン由来の水酸基の数に応じて適宜選択することができる。乳化剤としての機能を発揮し得る構造とは、親油基となる脂肪酸部位および親水基となる多価アルコール部位の両方を有する構造である。具体的には、ポリグリセリン脂肪酸エステル一分子あたりの脂肪酸エステル基の数は、通常1以上であればよい。また、グリセリン由来の水酸基の数は、1以上であればよい。 In addition, the number of fatty acid ester groups possessed by one polyglycerin fatty acid ester molecule is not limited as long as the polyglycerin fatty acid ester has a structure capable of exhibiting a function as an emulsifier, depending on the degree of polymerization of glycerin and the number of hydroxyl groups derived from glycerin. It can be selected as appropriate. A structure capable of functioning as an emulsifier is a structure having both a fatty acid portion serving as a lipophilic group and a polyhydric alcohol portion serving as a hydrophilic group. Specifically, the number of fatty acid ester groups per molecule of polyglycerol fatty acid ester is usually 1 or more. Moreover, the number of hydroxyl groups derived from glycerin should be 1 or more.
 ポリグリセリン脂肪酸エステルにおけるグリセリンの重合度、ならびに脂肪酸エステル基の種類および数は、上述したものを任意に組み合わせることができる。より具体的には、ポリグリセリン脂肪酸エステルのアルコール成分は、ジグリセリン、トリグリセリン、テトラグリセリン、ペンタグリセリン、ヘキサグリセリン、ヘプタグリセリン、オクタグリセリン、ノナグリセリン、またはデカグリセリンであってよい。ポリグリセリン脂肪酸エステルの酸成分は、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、リノール酸、またはα-リノレン酸等の脂肪酸であってよい。また、ポリグリセリン脂肪酸エステルは、モノエステル、ジエステル、トリエステル、テトラエステル、またはペンタエステル等であってよい。ポリグリセリン脂肪酸エステルとして、1種類を単独で用いてもよく、また2種類以上を任意の比率で併用してもよい。 The degree of polymerization of glycerin in the polyglycerin fatty acid ester and the type and number of fatty acid ester groups can be arbitrarily combined with those described above. More specifically, the alcohol component of the polyglycerin fatty acid ester can be diglycerin, triglycerin, tetraglycerin, pentaglycerin, hexaglycerin, heptaglycerin, octaglycerin, nonaglycerin, or decaglycerin. The acid component of the polyglycerol fatty acid ester can be a fatty acid such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, or α-linolenic acid. Also, the polyglycerin fatty acid ester may be a monoester, diester, triester, tetraester, pentaester, or the like. As the polyglycerol fatty acid ester, one type may be used alone, or two or more types may be used in combination at any ratio.
 ポリグリセリン脂肪酸エステルは、良好な香味および製造時の作業性の観点から、ジグリセリンモノ脂肪酸エステルおよびデカグリセリン脂肪酸エステルから選択される一種以上であることが好ましい。ジグリセリンモノ脂肪酸エステルは、ジグリセリンモノラウレート、ジグリセリンモノミリステート、ジグリセリンモノパルミテート、ジグリセリンモノステアレートおよびジグリセリンモノオレエートからなる群から選択されることが好ましく、ジグリセリンモノオレエートであることがより好ましい。デカグリセリン脂肪酸エステルは、デカグリセリンラウレート、デカグリセリンミリステート、デカグリセリンパルミテート、デカグリセリンステアレートおよびデカグリセリンオレエートからなる群から選択されることが好ましく、デカグリセリンモノラウレート、デカグリセリンモノミリステート、デカグリセリンモノパルミテート、デカグリセリンモノステアレートおよびデカグリセリンモノオレエートからなる群から選択されることがより好ましい。 The polyglycerin fatty acid ester is preferably one or more selected from diglycerin mono-fatty acid ester and decaglycerin fatty acid ester from the viewpoint of good flavor and workability during production. The diglycerin monofatty acid ester is preferably selected from the group consisting of diglycerin monolaurate, diglycerin monomyristate, diglycerin monopalmitate, diglycerin monostearate and diglycerin monooleate. Oleate is more preferred. The decaglycerin fatty acid ester is preferably selected from the group consisting of decaglycerin laurate, decaglycerin myristate, decaglycerin palmitate, decaglycerin stearate and decaglycerin oleate, and decaglycerin monolaurate, decaglycerin mono More preferably, it is selected from the group consisting of myristate, decaglycerin monopalmitate, decaglycerin monostearate and decaglycerin monooleate.
 前記組成物中のポリグリセリン脂肪酸エステルの含有率(ポリグリセリン脂肪酸エステルを2種類以上含有する場合は、それらの総含有率)は、限定されないが、良好な香味を得る観点および製造効率向上の観点から、通常0.1重量%以上であり、0.2量%以上であることが好ましく、0.3重量%以上であることがより好ましく、0.5重量%以上であることがさらに好ましい。また、前記ポリグリセリン脂肪酸エステルの含有率は、前記組成物に適度な粘性を付与する観点から、通常20.0重量%以下であり、15.0重量%以下であることが好ましく、10.0重量%以下であることがより好ましく、8.0重量%以下であることがさらに好ましい。 The content of the polyglycerol fatty acid ester in the composition (the total content of the polyglycerin fatty acid esters when two or more types of polyglycerol fatty acid esters are contained) is not limited, but from the viewpoint of obtaining a good flavor and improving the production efficiency. Therefore, it is usually 0.1% by weight or more, preferably 0.2% by weight or more, more preferably 0.3% by weight or more, further preferably 0.5% by weight or more. In addition, the content of the polyglycerin fatty acid ester is usually 20.0% by weight or less, preferably 15.0% by weight or less, from the viewpoint of imparting an appropriate viscosity to the composition, and 10.0% by weight or less. It is more preferably 8.0% by weight or less, more preferably 8.0% by weight or less.
 ポリグリセリン脂肪酸エステルのHLB値は、限定されないが、良好な香味を得る観点および製造効率向上の観点から、通常6.0以上、好ましくは7.0以上、また、通常20.0以下、好ましくは18.0以下、より好ましくは16.0以下である。 The HLB value of the polyglycerin fatty acid ester is not limited, but is usually 6.0 or more, preferably 7.0 or more, and usually 20.0 or less, preferably from the viewpoint of obtaining good flavor and improving production efficiency. It is 18.0 or less, more preferably 16.0 or less.
(6)離型剤
 前記組成物は、離型剤を含有することが好ましい。離型剤は、前記組成物を製造する際に成分が混合機、混錬機等の製造装置に付着したり、前記組成物をパウチ等の外装材に充填する際に成分が充填機等に付着したりする不都合を軽減し、製造効率を向上させることができる。また、離型剤は、前記組成物を構成する材料間の付着性を低減してケーキング(当該材料間の凝集や固化)を抑制し、また、前記組成物のべたつきを抑制することもできる。その結果、当該組成物を含むオーラル製品の外観、口触りといった使用感、香味等が向上する。また、前記組成物が外装材の外へ漏れることを抑制でき、オーラル製品の特性を向上することができる。
(6) Release agent The composition preferably contains a release agent. The release agent is such that when the composition is manufactured, the components adhere to a manufacturing device such as a mixer or kneader, or when the composition is filled into an exterior material such as a pouch, the components may adhere to a filling machine or the like. Problems such as adhesion can be reduced, and manufacturing efficiency can be improved. In addition, the release agent can reduce adhesion between materials constituting the composition to suppress caking (aggregation and solidification between the materials), and can also suppress stickiness of the composition. As a result, the oral product containing the composition is improved in appearance, feeling of use such as mouthfeel, flavor, and the like. In addition, the composition can be prevented from leaking out of the exterior material, and the properties of the oral product can be improved.
 離型剤は、上記作用効果を奏する限り限定されない。離型剤としては、例えば、微粒二酸化ケイ素、酸化マグネシウム、ケイ酸カルシウム、ケイ酸マグネシウム、リン酸カルシウム、ステアリン酸カルシウム、およびステアリン酸マグネシウム等の化合物が挙げられる。これらのうち、上記効果が高く、香味への影響も少ない点で、離型剤は二酸化ケイ素であることが好ましい。離型剤は、1種類を単独で用いてもよく、また、2種類以上を任意の比率で併用してもよい。 The release agent is not limited as long as it exhibits the above effects. Mold release agents include, for example, compounds such as particulate silicon dioxide, magnesium oxide, calcium silicate, magnesium silicate, calcium phosphate, calcium stearate, and magnesium stearate. Among these, silicon dioxide is preferred as the release agent because it has a high effect and little influence on flavor. One release agent may be used alone, or two or more release agents may be used in combination at any ratio.
 離型剤は、上記効果を十分発揮する観点から、粒子状であることが好ましい。当該粒子の平均粒径は、製造効率向上の観点から、通常20.0μm以下であり、15.0μm以下であることが好ましく、10.0μm以下であることがより好ましく、また、通常0.2μm以上であり、0.3μm以上であることが好ましく、0.4μm以上であることがより好ましく、1.0μm以上であることがさらに好ましい。本発明において、離型剤粒子の平均粒径は、レーザー回折粒度分布測定により求めた粒度分布における体積基準累積50%での粒径(D50)を意味する。レーザー回折粒度分布測定には、マルバーン・パナリティカル社製「マスターサイザー3000」のような汎用の装置を用いることができる。また、本発明においてこのような平均粒径を有する二酸化ケイ素を、「微粒二酸化ケイ素」と称することがある。 From the viewpoint of sufficiently exhibiting the above effects, the release agent is preferably particulate. From the viewpoint of improving production efficiency, the average particle diameter of the particles is usually 20.0 μm or less, preferably 15.0 μm or less, more preferably 10.0 μm or less, and usually 0.2 μm. That is, it is preferably 0.3 μm or more, more preferably 0.4 μm or more, and even more preferably 1.0 μm or more. In the present invention, the average particle size of the release agent particles means the particle size (D50) at 50% volume-based cumulative volume distribution in the particle size distribution determined by laser diffraction particle size distribution measurement. A general-purpose device such as "Mastersizer 3000" manufactured by Malvern Panalytical can be used for laser diffraction particle size distribution measurement. Further, in the present invention, silicon dioxide having such an average particle diameter may be referred to as "fine silicon dioxide".
 前記組成物中の離型剤の含有率(離型剤を2種類以上含有する場合は、それらの総含有率)は、限定されないが、良好な香味を確保し、かつ、上記効果を十分発揮する観点から、通常0.05重量%以上であり、0.1重量%以上であることが好ましく、0.5重量%以上であることがより好ましく、また、通常3.0重量%以下であり、2.5重量%以下であることが好ましく、2.0重量%以下であることがより好ましい。 The content of the release agent in the composition (when two or more release agents are contained, the total content thereof) is not limited, but ensures good flavor and sufficiently exhibits the above effects. From the viewpoint of , preferably 2.5% by weight or less, more preferably 2.0% by weight or less.
(7)水
 前記組成物中の水の含有率(含水率)は、前記組成物の製造容易性の観点から、通常5重量%以上である。さらに、前記組成物の製造効率向上、耐ケーキング性向上、べたつき抑制等の観点から、水の含有率の下限は30重量%以上であることが好ましく、45重量%以上であることがより好ましく、その上限は通常60重量%以下であり、50重量%以下であることが好ましい。また、水の含有率は40重量%以下であってもよく、30重量%以下であってもよく、20重量%以下であってもよい。水の含有率は、添加する水の量を調整したり、製造段階で加熱処理や乾燥処理を設けたりすることによって調整することができる。前記組成物の水の含有率は、製品のタイプ(モイストまたはドライ)に応じて適宜調整される。例えばモイストタイプの場合、水の含有率は通常20~60重量%であり、好ましくは30~50重量%である。一方、ドライタイプの場合、水の含有率は通常5~20重量%であり、好ましくは10~15重量%である。
(7) Water The content of water (water content) in the composition is usually 5% by weight or more from the viewpoint of ease of production of the composition. Furthermore, the lower limit of the water content is preferably 30% by weight or more, more preferably 45% by weight or more, from the viewpoint of improving production efficiency of the composition, improving caking resistance, suppressing stickiness, etc. The upper limit is usually 60% by weight or less, preferably 50% by weight or less. Also, the water content may be 40% by weight or less, 30% by weight or less, or 20% by weight or less. The water content can be adjusted by adjusting the amount of water to be added or by providing heat treatment or drying treatment in the production stage. The water content of the composition is adjusted accordingly depending on the product type (moist or dry). For example, in the case of moist type, the water content is usually 20 to 60% by weight, preferably 30 to 50% by weight. On the other hand, in the dry type, the water content is usually 5-20% by weight, preferably 10-15% by weight.
 前記組成物の水の含有率(含水率)は、加熱乾燥式水分計(例えば、METTER TOLEDO社製:HB 43-S)を用いて測定することができる。測定に際し、試料を所定容器に投入し到達温度100℃まで加熱する。測定は60秒間で1mg以下の変化量となった時点で終了し、加熱前後の秤量値より含水率を算出する。 The water content (moisture content) of the composition can be measured using a heat drying moisture meter (for example, HB 43-S manufactured by METER TOLEDO). At the time of measurement, the sample is placed in a predetermined container and heated to reach a temperature of 100°C. The measurement is terminated when the amount of change becomes 1 mg or less in 60 seconds, and the moisture content is calculated from the weighed values before and after heating.
(8)その他
 前記組成物は、上記以外にその他の物質を含んでいてもよい。その他の物質としては、例えば、香料、pH調整剤、甘味料(糖アルコールを除く)、保湿剤、苦味抑制剤、白色剤(二酸化ケイ素を除く)、および乳化剤(ポリグリセリン脂肪酸エステルを除く)等が挙げられる。当該物質の含有率は、限定されず、製品設計に応じて適宜配合を調整することができる。
(8) Others The composition may contain substances other than those mentioned above. Other substances include, for example, flavors, pH adjusters, sweeteners (excluding sugar alcohols), humectants, bitterness inhibitors, whitening agents (excluding silicon dioxide), and emulsifiers (excluding polyglycerin fatty acid esters). is mentioned. The content of the substance is not limited, and the composition can be appropriately adjusted according to the product design.
 1)香料
 香料は限定されず、例えば、メンソール、葉たばこ抽出エキス、天然植物性香料(例えば、シナモン、セージ、ハーブ、カモミール、葛草、甘茶、クローブ、ラベンダー、カルダモン、チョウジ、ナツメグ、ベルガモット、ゼラニウム、蜂蜜エッセンス、ローズ油、レモン、オレンジ、ケイ皮、キャラウェー、ジャスミン、ジンジャー、コリアンダー、バニラエキス、スペアミント、ペパーミント、カシア、コーヒー、セロリー、カスカリラ、サンダルウッド、ココア、イランイラン、フェンネル、アニス、リコリス、セントジョンズブレッド、スモモエキス、ピーチエキス等)、糖類(例えば、グルコース、フルクトース、異性化糖、カラメル、蜂蜜、糖蜜等)、ココア類(パウダー、エキス等)、エステル類(例えば、酢酸イソアミル、酢酸リナリル、プロピオン酸イソアミル、酪酸リナリル等)、ケトン類(例えば、メントン、イオノン、ダマセノン、エチルマルトール等)、アルコール類(例えば、ゲラニオール、リナロール、アネトール、オイゲノール等)、アルデヒド類(例えば、バニリン、ベンズアルデヒド、アニスアルデヒド等)、ラクトン類(例えば、γ-ウンデカラクトン、γ-ノナラクトン等)、動物性香料(例えば、ムスク、アンバーグリス、シベット、カストリウム等)、および炭化水素類(例えば、リモネン、ピネン等)が挙げられる。香料として1種類を単独で用いてもよく、また2種類以上を任意の比率で併用してもよい。
1) Fragrances Flavors are not limited, and examples include menthol, leaf tobacco extract, natural plant flavors (e.g., cinnamon, sage, herbs, chamomile, kudzu grass, sweet tea, cloves, lavender, cardamom, clove, nutmeg, bergamot, geranium). , Honey Essence, Rose Oil, Lemon, Orange, Cinnamon, Caraway, Jasmine, Ginger, Coriander, Vanilla Extract, Spearmint, Peppermint, Cassia, Coffee, Celery, Cascarilla, Sandalwood, Cocoa, Ylang Ylang, Fennel, Anise, licorice, St. John's bread, plum extract, peach extract, etc.), sugars (e.g., glucose, fructose, isomerized sugar, caramel, honey, molasses, etc.), cocoa (powder, extract, etc.), esters (e.g., isoamyl acetate) , linalyl acetate, isoamyl propionate, linalyl butyrate, etc.), ketones (e.g., menthone, ionone, damascenone, ethyl maltol, etc.), alcohols (e.g., geraniol, linalool, anethole, eugenol, etc.), aldehydes (e.g., vanillin , benzaldehyde, anisaldehyde, etc.), lactones (e.g., γ-undecalactone, γ-nonalactone, etc.), animal fragrances (e.g., musk, ambergris, civet, castoreum, etc.), and hydrocarbons (e.g., limonene , pinene, etc.). As a perfume, one type may be used alone, or two or more types may be used together in an arbitrary ratio.
 2)pH調整剤
 pH調整剤は限定されず、例えば、炭酸ナトリウム、炭酸水素ナトリウム、炭酸カリウム、炭酸水素カリウム、リン酸カリウム、無水リン酸ナトリウム、リン酸二水素ナトリウム、およびクエン酸ナトリウム等が挙げられる。中でも、製品の呈味への影響の観点から、炭酸ナトリウム、炭酸カリウム、またはリン酸二水素ナトリウムが好ましい。pH調整剤として1種類を単独で用いてもよく、また2種類以上を任意の比率で併用してもよい。
2) pH adjuster The pH adjuster is not limited, and examples thereof include sodium carbonate, sodium hydrogen carbonate, potassium carbonate, potassium hydrogen carbonate, potassium phosphate, anhydrous sodium phosphate, sodium dihydrogen phosphate, and sodium citrate. mentioned. Among them, sodium carbonate, potassium carbonate, or sodium dihydrogen phosphate is preferable from the viewpoint of influence on the taste of the product. As a pH adjuster, one type may be used alone, or two or more types may be used together in an arbitrary ratio.
 3)甘味料
 甘味料としては、限定されないが、例えばキシリトール、マルチトール、エリスリトール等の糖アルコール;およびアセスルファムカリウム、スクラロース、アスパルテーム等が挙げられる。味の調節の観点から糖アルコールが好ましい。甘味料は、1種類を単独で用いてもよく、また、2種類以上を任意の比率で併用してもよい。
3) Sweeteners Sweeteners include, but are not limited to, sugar alcohols such as xylitol, maltitol, erythritol; and acesulfame potassium, sucralose, aspartame, and the like. Sugar alcohols are preferred from the viewpoint of taste control. One type of sweetener may be used alone, or two or more types may be used in combination at any ratio.
 4)苦味抑制剤
 苦味抑制剤は限定されないが、例えば、大豆レシチンが挙げられる。大豆レシチンとはリン脂質であり、具体的にホスファチジルコリン、ホスファチジルエタノールアミン、およびホスファチジン酸等が挙げられる。苦味抑制剤として1種類を単独で用いてもよく、また2種類以上を任意の比率で併用してもよい。
4) Bitterness inhibitors Bitterness inhibitors are not limited, but include, for example, soybean lecithin. Soybean lecithin is a phospholipid, specifically phosphatidylcholine, phosphatidylethanolamine, phosphatidic acid, and the like. As bitterness inhibitors, one type may be used alone, or two or more types may be used in combination at an arbitrary ratio.
 5)保湿剤
 保湿剤は限定されないが、例えば、グリセリンやプロピレングリコール等の多価アルコールが挙げられる。製品保存性の観点から、グリセリンが好ましい。保湿剤として1種類を単独で用いてもよく、また2種類以上を任意の比率で併用してもよい。
5) Moisturizers Moisturizers are not limited, but examples thereof include polyhydric alcohols such as glycerin and propylene glycol. Glycerin is preferred from the viewpoint of product storage stability. As a moisturizing agent, one kind may be used alone, or two or more kinds may be used together in an arbitrary ratio.
 6)白色剤
 白色剤は限定されないが、例えば、微粒二酸化ケイ素、二酸化チタン、または炭酸カルシウム等が挙げられる。製品への味の影響の観点から、微粒二酸化ケイ素が好ましい。白色剤として1種類を単独で用いてもよく、また2種類以上を任意の比率で併用してもよい。
6) Whitening agent The whitening agent is not limited, but examples thereof include fine silicon dioxide, titanium dioxide, calcium carbonate, and the like. From the point of view of the taste impact on the product, finely divided silicon dioxide is preferred. As the whitening agent, one kind may be used alone, or two or more kinds may be used together in an arbitrary ratio.
 7)乳化剤、界面活性剤
 乳化剤(ポリグリセリン脂肪酸エステルを除く)は限定されないが、例えば、食品に添加される乳化剤を挙げることができる。乳化剤としては、ショ糖脂肪酸エステル、有機酸グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステルおよびレシチンからなる群から選ばれる一種以上を挙げることができる。ショ糖脂肪酸エステルとして、ショ糖パルミチン酸エステルおよびショ糖ステアリン酸エステルを挙げることができる。有機酸グリセリン脂肪酸エステルとして、コハク酸グリセリン脂肪酸エステルおよびジアセチル酒石酸グリセリン脂肪酸エステルを挙げることができる。ポリグリセリン脂肪酸エステルとして、デカグリセリン脂肪酸エステルを挙げることができる。前記組成物における乳化剤の含有率は、前述のポリグリセリン脂肪酸エステルとの合計含有率が、ポリグリセリン脂肪酸エステルの含有率として上述した範囲内となる量であることが好ましい。
7) Emulsifiers, Surfactants Emulsifiers (excluding polyglycerol fatty acid esters) are not limited, but include, for example, emulsifiers added to foods. Examples of emulsifiers include one or more selected from the group consisting of sucrose fatty acid esters, organic acid glycerin fatty acid esters, polyglycerin fatty acid esters and lecithin. Sucrose fatty acid esters include sucrose palmitate and sucrose stearate. Examples of the organic acid glycerol fatty acid ester include succinic acid glycerol fatty acid ester and diacetyltartaric acid glycerol fatty acid ester. Examples of polyglycerin fatty acid esters include decaglycerin fatty acid esters. The content of the emulsifier in the composition is preferably such that the total content of the polyglycerol fatty acid ester and the polyglycerol fatty acid ester is within the above range.
 9)ゲル化剤、ゲル化補助剤
 ゲル化剤としては、カルボキシル基を有する多糖類が好ましく、例えば、カラギーナン、ペクチン、アラビアガム、キサンタン、ジェラン、トラガントガム、またはアルギン酸が好ましい。さらに、カルシウムイオンの存在下でゲル化しやすく、カルボキシル基と陽イオンでジャンクションゾーンを作り架橋構造を形成することができる観点から、カラギーナン、ペクチン、ジェラン、またはアルギン酸が好ましい。これらの中でも、後述する理由から、LMペクチンが好ましい。これらは、1種類を単独で用いてもよく、また2種類以上を任意の比率で併用してもよい。
9) Gelling Agents and Gelling Aids As gelling agents, polysaccharides having carboxyl groups are preferred, such as carrageenan, pectin, gum arabic, xanthan, gellan, gum tragacanth, or alginic acid. Furthermore, carrageenan, pectin, gellan, or alginic acid is preferable from the viewpoints that gelation is likely to occur in the presence of calcium ions and that a junction zone can be formed between carboxyl groups and cations to form a crosslinked structure. Among these, LM pectin is preferred for reasons described later. One of these may be used alone, or two or more of them may be used in combination at any ratio.
 ゲル化補助成分としては、例えばカルシウムイオンが挙げられ、その供給源(ゲル化補助剤)は、は限定されないが、例えば、カルシウムのハロゲン酸塩(塩化物等)、クエン酸、炭酸塩、硫酸塩、リン酸塩、および乳酸塩等が挙げられる。これらのうち、味への影響が少ない、溶解性が高い、および溶解後のpHの観点から、乳酸カルシウム、炭酸カルシウム、またはリン酸カルシウムが好ましく、特に、乳酸カルシウムが好ましい。これらは1種類を単独で用いてもよく、また2種類以上を任意の比率で併用してもよい。 Examples of the gelling aid component include calcium ions, and the source thereof (gelling aid) is not limited, but examples include calcium halides (chlorides, etc.), citric acid, carbonate, sulfuric acid, and the like. salts, phosphates, lactates, and the like. Among these, calcium lactate, calcium carbonate, or calcium phosphate is preferable, and calcium lactate is particularly preferable, from the viewpoints of little influence on taste, high solubility, and pH after dissolution. One of these may be used alone, or two or more of them may be used in combination at any ratio.
 カルシウムイオン以外のゲル化補助成分としては、例えば、カルシウムイオンと同様にゲル化剤をイオン結合で結合させることができるマグネシウム、銀、亜鉛、銅、金、またはアルミニウム等の金属イオン、およびカチオン性高分子のイオン等が挙げられる。これらの供給源(その他のゲル化補助剤)としては、例えば、これらの金属イオンのハロゲン酸塩(塩化物等)、クエン酸、炭酸塩、硫酸塩、リン酸塩、およびカチオン性高分子等が挙げられる。これらは1種類を単独で用いてもよく、また2種類以上を任意の比率で併用してもよい。 Gelation aids other than calcium ions include, for example, metal ions such as magnesium, silver, zinc, copper, gold, and aluminum that can bind gelling agents with ionic bonds in the same manner as calcium ions, and cationic Examples include ions of macromolecules. Sources of these (other gelling aids) include, for example, halides (chlorides, etc.) of these metal ions, citric acid, carbonates, sulfates, phosphates, cationic polymers, and the like. are mentioned. One of these may be used alone, or two or more of them may be used in combination at any ratio.
(9)特性
 1)流動性
 前記組成物の流動性により、当該組成物の粘性、製造装置への付着性、耐ケーキング性、およびべたつきを評価することができる。当該流動性は、測定温度22℃における垂直応力5.0kPaでの剪断応力の値を相対比較して評価される。垂直応力5.0kPaは、前記組成物の製造装置への付着、ケーキング、べたつきが生じ得る条件として、製造中、搬送中、保管中等に自重により前記組成物に加えられると想定される圧力負荷である。当該剪断応力は、好ましくは4.15kPa以上、より好ましくは4.20kPa以上、さらに好ましくは4.25kPa以上、また、好ましくは5.85kPa以下、より好ましくは5.80kPa以下である。
(9) Characteristics 1) Fluidity The fluidity of the composition allows evaluation of the viscosity, adhesion to production equipment, caking resistance, and stickiness of the composition. The fluidity is evaluated by relatively comparing shear stress values at a measurement temperature of 22° C. and a normal stress of 5.0 kPa. The normal stress of 5.0 kPa is a pressure load assumed to be applied to the composition by its own weight during manufacturing, transportation, storage, etc., as a condition that may cause adhesion, caking, and stickiness of the composition to the manufacturing apparatus. be. The shear stress is preferably 4.15 kPa or more, more preferably 4.20 kPa or more, still more preferably 4.25 kPa or more, and preferably 5.85 kPa or less, more preferably 5.80 kPa or less.
 上記の垂直応力5.0kPaでの組成物の剪断応力は、レオメーターを用いて測定することができる。例えば、レオメーターとしてフリーマンテクノロジー社製のパウダーレオメーターFT4を用いた場合、下記の測定条件で測定される。
・測定モード:stantard program (25mm_shear_9kPa)
・測定温度:22℃
・測定湿度:60%RH
・測定容器:内径25mmの円筒容器、容積10ml
・垂直荷重:3~9kPa
 測定原料をそれぞれ篩(1.18mm目開き)にかけ、粒子を細かく均一にしたものを測定サンプルとし、上記レオメーターの手順に沿って測定を行う。
The shear stress of the composition at the above normal stress of 5.0 kPa can be measured using a rheometer. For example, when powder rheometer FT4 manufactured by Freeman Technology Co., Ltd. is used as the rheometer, measurement is performed under the following measurement conditions.
・Measurement mode: standard program (25mm_shear_9kPa)
・Measurement temperature: 22°C
・Measurement humidity: 60% RH
・Measurement container: Cylindrical container with an inner diameter of 25 mm and a volume of 10 ml
・Vertical load: 3 to 9 kPa
Each raw material to be measured is passed through a sieve (1.18 mm mesh size) to make fine and uniform particles, which is used as a measurement sample, and the measurement is performed according to the procedure of the rheometer described above.
 2)粒度
 前記組成物は、固体の複数の粒状物から構成されることが好ましいが、その粒状物のサイズは、限定されない。ユーザーの使用時の口触りの良さ、製造時の扱いやすさ、および品質のばらつきを制御する観点から、乾燥させた組成物は、通常は15mmの篩目を有する篩を通過(<15mm)サイズであり、10mmの篩目を有する篩を通過するサイズ(<10mm)であることが好ましく、5mmの篩目を有する篩を通過するサイズ(<5mm)であることがより好ましく、3.2mmの篩目を有する篩を通過するサイズ(<3.2mm)であることがさらに好ましい。例えば、含水率が5重量%以下となるよう乾燥した組成物の全てが3.2mmの篩目の篩を通過した場合、当該組成物の乾燥時の最大粒度が3.2mm以下であることを表す。乾燥時の組成物の粒度の下限を設定する必要はないが、パウチからの漏れを防ぐ観点から、通常3μm以上である。
2) Particle size The composition is preferably composed of a plurality of solid particles, but the size of the particles is not limited. The dried composition is usually passed through a sieve having a 15 mm mesh (<15 mm) size in terms of user mouthfeel, ease of handling during manufacturing, and control of quality variability. is preferably a size (<10 mm) that passes through a sieve with a 10 mm mesh, more preferably a size (<5 mm) that passes through a sieve with a 5 mm mesh, and 3.2 mm More preferably, it is of a size (<3.2 mm) that passes through a sieve with sieve mesh. For example, if all of the composition dried to a moisture content of 5% by weight or less passes through a sieve with a sieve mesh of 3.2 mm, the maximum particle size of the composition when dried is 3.2 mm or less. show. Although it is not necessary to set the lower limit of the particle size of the dry composition, it is usually 3 μm or more from the viewpoint of preventing leakage from the pouch.
 上記の乾燥した組成物の調製方法は、含水率を5重量%以下まで低下させることができる限り限定されないが、例えば口腔用組成物を常温、70℃~80℃等の温度条件で所定の時間静置することにより調製する方法が挙げられる。組成物の最大粒度は、例えばニコチンが担持されたイオン交換樹脂の粒度、含水率等を調整することにより適宜調整できる。 The method for preparing the above dried composition is not limited as long as the water content can be reduced to 5% by weight or less. A method of preparing by allowing to stand can be mentioned. The maximum particle size of the composition can be appropriately adjusted, for example, by adjusting the particle size of the nicotine-supported ion exchange resin, the moisture content, and the like.
 3)pH
 前記組成物のpHは限定されないが、味への影響の観点から、通常7.0以上であり、7.5以上であることが好ましく、8.0以上であることがより好ましく、また、通常10.0以下であり、9.5以下であることが好ましく、9.0以下であることがより好ましい。当該pHは25℃における測定値である。
3) pH
Although the pH of the composition is not limited, it is usually 7.0 or higher, preferably 7.5 or higher, more preferably 8.0 or higher, from the viewpoint of influence on taste. It is 10.0 or less, preferably 9.5 or less, more preferably 9.0 or less. The pH is a measured value at 25°C.
 測定温度25℃における組成物のpHは、pH分析計(例えば、堀場製作所製:LAQUA F-72 フラットISFET pH電極)を用い、組成物2gに対して、水20mL投入し10分間振とうし、その上清液を測定することで測定することができる。機器の校正は、例えば、フタル酸pH標準液(pH4.01)、中性リン酸塩pH標準液(pH6.86)、ほう酸塩pH標準液(pH9.18)(いずれも和光純薬工業)を用いた3点校正で行うことが好ましい。 The pH of the composition at a measurement temperature of 25° C. was measured using a pH analyzer (for example, LAQUA F-72 flat ISFET pH electrode manufactured by Horiba Ltd.). It can be measured by measuring the supernatant. For calibration of the device, for example, phthalic acid pH standard solution (pH 4.01), neutral phosphate pH standard solution (pH 6.86), borate pH standard solution (pH 9.18) (all Wako Pure Chemical Industries) It is preferable to perform a three-point calibration using
2.オーラル製品
 オーラル製品とは、前記組成物を口中に含むことができるように成形された製品である。製品形態は、公知のとおりとすることができる。その例としては、噛みたばこ、パウチ、錠剤、ガム、フィルム、および液体の形態が挙げられる。噛みたばこ製品とは、咀嚼することで、組成物に含まれるニコチンが唾液と混合されて摂取される製品をいう。パウチ製品とはシールされた非水溶性外装材(パウチともいう)内に組成物(主材または充填物ともいう)を備え、唾液がパウチを通って浸透しパウチ内に包含された組成物中の成分を溶解し、その後、パウチを通り抜けて口腔中に運び出し得る製品をいう。錠剤製品は口中で徐々に溶解または崩壊させて、口腔、咽頭などから組成物中の成分を摂取する製品をいう。錠剤製品としては、トローチ、チュアブル、またはドロップ等のタイプがある。ガム製品とは、使用者が咀嚼することで、組成物中に含まれる成分が唾液と混合され口腔粘膜を通し吸収される製品をいう。ガム製品としては咀嚼型ガムまたはバブル型ガム等のタイプがある。フィルム製品とは、口腔適用時に唾液等の水分によって口腔粘膜へ付着する製品をいう。粘膜を介して組成物中に含まれる成分が摂取される。液体製品は、スプレーまたは滴下によって口腔内に適用され、口腔粘膜を介して組成物中の成分を摂取する製品をいう。
2. Oral Products Oral products are products shaped so that the composition can be contained in the mouth. The product form can be as known. Examples include chewing tobacco, pouches, tablets, gums, films, and liquid forms. A chewing tobacco product is a product in which the nicotine contained in the composition is mixed with saliva and ingested by chewing. Pouch products include a composition (also referred to as a main material or filler) within a sealed water-insoluble exterior material (also referred to as a pouch), and saliva permeates through the pouch and is contained within the pouch. It is a product that can dissolve the ingredients of the product and then pass through the pouch and be carried into the oral cavity. A tablet product refers to a product that is slowly dissolved or disintegrated in the mouth and the components of the composition are ingested from the oral cavity, pharynx, or the like. Tablet products include types such as troches, chewables, or drops. The term "gum product" refers to a product in which the ingredients contained in the composition are mixed with saliva and absorbed through the oral mucosa by chewing by the user. Gum products include types such as chewable gum or bubble gum. A film product refers to a product that adheres to the oral mucosa due to moisture such as saliva when applied to the oral cavity. Ingredients contained in the composition are ingested through the mucous membrane. A liquid product refers to a product that is applied to the oral cavity by spraying or dripping and ingests the ingredients in the composition through the oral mucosa.
 オーラル製品が、パウチまたはガム等のように外装材と主材を備える場合、主材は前記組成物であることが好ましい。また、成分(B)である難消化デキストリンは外装材、主材、またはその双方に含有されることもできる。この場合、主材は前記組成物またはこれに準ずる組成物であってよいが、成分(B)の量は、その総量が1製品当たり3~9gの量または1製品当たり0.5~1gの量となるように調整される。 When the oral product comprises an exterior material and a main material such as a pouch or gum, the main material is preferably the above composition. In addition, the indigestible dextrin, which is the component (B), can also be contained in the exterior material, the main material, or both. In this case, the main material may be the above composition or a composition similar thereto, but the total amount of component (B) is 3 to 9 g per product or 0.5 to 1 g per product. Adjusted for quantity.
 本発明のオーラル製品は、一態様において1製品当たり3~9gの量の難消化デキストリン(B)を含む(第1のオーラル製品)。非特許文献1によれば、1食あたりの平均炭水化物量は116g程度である。グルコース100重量部に対し3~7重量部の成分(B)を摂取しようとする場合、平均炭水化物量は116gに対する成分(B)の量は3.6~8.1gである。したがって、1製品当たり3~9gの量の難消化デキストリン(B)を含む第1のオーラル製品は、グルコースの摂取中または摂取後に1個の製品を使用すれば、前記グルコース100重量部に対し3~7重量部の成分(B)を摂取することが可能となる。第1のオーラル製品は、1つあたりの重量が3g以上であるので、錠剤またはガムの形態が特に適している。 In one aspect, the oral product of the present invention contains an amount of indigestible dextrin (B) of 3 to 9 g per product (first oral product). According to Non-Patent Document 1, the average amount of carbohydrates per meal is about 116 g. When trying to ingest 3-7 parts by weight of component (B) per 100 parts by weight of glucose, the amount of component (B) is 3.6-8.1 g for an average carbohydrate amount of 116 g. Therefore, the first oral product containing indigestible dextrin (B) in an amount of 3 to 9 g per product is 3 g per 100 parts by weight of glucose if one product is used during or after ingestion of glucose. It becomes possible to ingest ~7 parts by weight of component (B). Since the first oral product weighs 3g or more per piece, tablet or gum form is particularly suitable.
 本発明のオーラル製品は、別態様において1製品当たり0.5~1gの量の難消化デキストリン(B)を含む(第2のオーラル製品)。前述のとおり、グルコース100重量部に対し3~7重量部の成分(B)を摂取しようとする場合、平均炭水化物量は116gに対する成分(B)の量は3.6~8.1gである。したがって、1製品当たり0.5~1gの量の難消化デキストリン(B)を含む第2のオーラル製品は、グルコースの摂取中または摂取後に4~8個の製品を使用すれば、前記グルコース100重量部に対し3~7重量部の成分(B)を摂取することが可能となる。第2のオーラル製品が、1個の製品を連続させてなる2連タイプまたは4連タイプであると、使用時の利便性が高い。したがって、第2のオーラル製品は複数連タイプとしやすいパウチの形態が特に適している。本発明においては第2のオーラル製品が特に好ましいので、以下、当該製品を例にして説明する。 In another aspect, the oral product of the present invention contains indigestible dextrin (B) in an amount of 0.5 to 1 g per product (second oral product). As mentioned above, when trying to ingest 3-7 parts by weight of component (B) for 100 parts by weight of glucose, the amount of component (B) is 3.6-8.1 g for an average carbohydrate amount of 116 g. Therefore, a second oral product containing indigestible dextrin (B) in an amount of 0.5-1 g per product can be used for 100 wt. It is possible to take 3 to 7 parts by weight of component (B) per part. If the second oral product is a double or quadruple type in which one product is continuously connected, it is highly convenient to use. Therefore, the second oral product is particularly suitable in the form of a pouch, which is easy to use as a multi-slot type. Since the second oral product is particularly preferable in the present invention, the product will be described below as an example.
 第2のオーラル製品はオーラルパウチ製品とも称される。オーラルパウチ製品は、主材(充填物ともいう)と、当該主材を包装する外装材(パウチともいう)を備える。 The second oral product is also called an oral pouch product. An oral pouch product comprises a main material (also called a filler) and an exterior material (also called a pouch) for packaging the main material.
(1)パウチ
 パウチは、充填物を包装することができ、水に溶解せず、かつ、液体(水や唾液等)および充填物中の水溶性成分を透過できれば、限定されず公知のものを用いることができる。パウチの材料としては、例えば、セルロース系の不織布等が挙げられ、市販の不織布を用いてもよい。このような材料からなるシートを袋形状に成形し、その中に充填物を充填し、ヒートシール等の手段によりシールすることによりパウチ製品を作製することができる。
(1) Pouch Pouches are not limited to known ones, as long as they can pack a filling, do not dissolve in water, and can permeate liquids (water, saliva, etc.) and water-soluble components in the filling. can be used. Materials for the pouch include, for example, cellulose-based nonwoven fabrics, and commercially available nonwoven fabrics may be used. A pouch product can be produced by forming a sheet made of such a material into a bag shape, filling the bag with a filler, and sealing the bag by means of heat sealing or the like.
 上記のシートの坪量は、特段制限されず、通常12gsm以上、54gsm以下であり、24gsm以上、30gsm以下であることが好ましい。上記のシートの厚さは、特段制限されず、通常100μm以上、300μm以下であり、175μm以上、215μm以下であることが好ましい。 The basis weight of the sheet is not particularly limited, and is usually 12 gsm or more and 54 gsm or less, preferably 24 gsm or more and 30 gsm or less. The thickness of the sheet is not particularly limited, and is usually 100 μm or more and 300 μm or less, preferably 175 μm or more and 215 μm or less.
 パウチの内面および外面の少なくとも一方に部分的に撥水材料が塗布されていてもよい。撥水材料としては撥水性フッ素系樹脂が好適である。具体的には、この種の撥水性フッ素系樹脂としては、旭硝子社製のアサヒガード(登録商標)が挙げられる。撥水性フッ素系樹脂は、例えば、菓子類、乳製品、惣菜、ファストフードやペットフードなどの油脂類を含んだ食品や製品のための包材に塗布されている。それ故、この種の撥水性フッ素系樹脂は、口腔内に置かれるパウチに塗布されても安全である。この撥水材料としてはフッ素系樹脂に限ることなく、例えば、パラフィン樹脂、シリコン系樹脂またはエポキシ系樹脂等の撥水作用を有する材料であってもよい。 At least one of the inner and outer surfaces of the pouch may be partially coated with a water-repellent material. A water-repellent fluorine-based resin is suitable as the water-repellent material. Specifically, this type of water-repellent fluorine-based resin includes Asahi Guard (registered trademark) manufactured by Asahi Glass Co., Ltd. Water-repellent fluorine-based resins are applied to packaging materials for foods and products containing oils and fats, such as confectionery, dairy products, side dishes, fast food, and pet food. Therefore, this type of water-repellent fluororesin is safe even when applied to pouches placed in the oral cavity. The water-repellent material is not limited to the fluorine-based resin, and may be, for example, a material having a water-repellent action such as a paraffin resin, a silicon-based resin, or an epoxy-based resin.
 パウチは、難消化デキストリン(成分(B))を含有することができる。例えば、成分(B)を分散させた分散液をパウチに塗布、噴霧、または含侵させることによって成分(B)を含有するパウチを調製できる。またパウチは、任意の成分を含んでいてよい。当該成分としては、例えば、香りや味を調節する原料や、香料、添加物、たばこ抽出液、および色素等が挙げられる。また、これらの成分を含有させる態様は限定されず、パウチ表面に塗布したり、しみこませたり、繊維からなる場合には該繊維に含有させる態様等が挙げられる。 The pouch can contain indigestible dextrin (component (B)). For example, a pouch containing component (B) can be prepared by coating, spraying, or impregnating a pouch with a dispersion in which component (B) is dispersed. The pouch may also contain optional ingredients. Examples of such components include raw materials that adjust aroma and taste, flavors, additives, tobacco extracts, pigments, and the like. In addition, the manner in which these components are contained is not limited, and examples thereof include the manner in which they are applied to the surface of the pouch, the manner in which they are impregnated, and the manner in which they are contained in the fibers when they are made of fibers.
 パウチの外観も限定されない。パウチは、非透明、半透明、または透明であってよい。パウチが半透明または透明であると充填物が透けてみえる。 The appearance of the pouch is also not limited. Pouches may be non-transparent, translucent, or transparent. The filling can be seen through if the pouch is translucent or transparent.
 オーラルパウチ製品のサイズは限定されない。使用前の製品のサイズは、長辺の下限が25mm以上、28mm以上、35mm以上、または38mm以上であってよい。またその上限は40mm以下であってよい。短辺の下限は10mm以上または14mm以上であってよい。またその上限は、20mm以下または18mm以下であってよい。オーラルパウチ製品の全重量に対する充填物の重量の割合は、限定されないが、通常80重量%以上であり、85重量%以上であることが好ましく、90重量%以上であることがより好ましく、また、通常99重量%以下であり、97重量%以下であることが好ましく、95重量%以下であることがより好ましい。 The size of oral pouch products is not limited. The size of the product before use may have a lower long dimension of 25 mm or greater, 28 mm or greater, 35 mm or greater, or 38 mm or greater. Moreover, the upper limit may be 40 mm or less. The lower limit of the short side may be 10 mm or more or 14 mm or more. Moreover, the upper limit may be 20 mm or less or 18 mm or less. The ratio of the weight of the filler to the total weight of the oral pouch product is not limited, but is usually 80% by weight or more, preferably 85% by weight or more, more preferably 90% by weight or more, and It is usually 99% by weight or less, preferably 97% by weight or less, more preferably 95% by weight or less.
(2)充填物
 オーラルパウチ製品1個当たりの充填物の量は、好ましくは0.5mg~25mgである。オーラルパウチ製品は、外装材、充填物、またはその双方に成分(B)を含有させることができる。外装材に成分(B)を含有させる場合、最終的な成分(B)の量が、所望の量(オーラルパウチ製品の場合は1個の製品あたり0.5~1g、他の製品においても同様。)となるように調整される。
(2) Filling The amount of filling per oral pouch product is preferably 0.5 mg to 25 mg. Oral pouch products can contain component (B) in the outer packaging, filler, or both. When the outer packaging material contains component (B), the final amount of component (B) is the desired amount (0.5 to 1 g per product for oral pouch products, the same for other products ) is adjusted to be
3.製造方法
(1)オーラル製品用組成物の製造
 当該組成物は、任意の方法で製造されるが、少なくともニコチン(成分(A))および難消化デキストリン(成分(B))と、必要に応じて基材、糖アルコール、ポリグリセリン脂肪酸エステル、および離型剤を混合する工程を経て製造されることが好ましい。混合は、全原料をミキサーに投入して混合することで実施できる。
3. Production method (1) Production of oral product composition It is preferably produced through a step of mixing a base material, sugar alcohol, polyglycerin fatty acid ester, and a release agent. Mixing can be accomplished by placing all ingredients in a mixer and mixing.
 好ましい製造方法では、まず、ニコチン(成分(A))、難消化デキストリン(成分(B))、基材、糖アルコール、離型剤、ならびに必要に応じて水およびその他の物質(甘味料、香料、保湿剤等)を混合して第1の混合物を得る。このとき加熱を施してもよい。また、各原料の混合の順序は限定されず、任意の順序または同時にミキサーに投入して混合してもよく、固形の原料を均一に混合した後に液体の原料を添加してさらに混合してもよい。作業性の観点からは、後者の態様が好ましい。 In a preferred production method, first, nicotine (component (A)), indigestible dextrin (component (B)), base material, sugar alcohol, release agent, and optionally water and other substances (sweetener, flavor , moisturizing agent, etc.) to obtain a first mixture. Heating may be applied at this time. In addition, the order of mixing each raw material is not limited, and they may be put into a mixer in any order or at the same time and mixed, or after uniformly mixing the solid raw materials, the liquid raw materials may be added and further mixed. good. From the viewpoint of workability, the latter mode is preferred.
 次に、第1の混合物を撹拌しながら、第1の混合物にポリグリセリン脂肪酸エステル溶液を噴霧することで、第1の混合物とポリグリセリン脂肪酸エステルとを混合し、第2の混合物を得る。ポリグリセリン脂肪酸エステルがアンチケーキング効果を発揮するため、以降の工程において、ケーキングが生じにくくなる。上記ポリグリセリン脂肪酸エステル溶液の溶媒は、ポリグリセリン脂肪酸エステルを溶解させることができる限り限定されないが、エタノール等のアルコール溶媒であることが好ましい。ポリグリセリン脂肪酸エステル溶液の溶媒を第2の混合物中に多量に残存させないため、第1の混合物にポリグリセリン脂肪酸エステル溶液を噴霧している間または噴霧終了後に加熱処理を施してもよい。 Next, while stirring the first mixture, the polyglycerin fatty acid ester solution is sprayed onto the first mixture to mix the first mixture and the polyglycerin fatty acid ester to obtain a second mixture. Since the polyglycerol fatty acid ester exerts an anti-caking effect, caking is less likely to occur in subsequent steps. The solvent for the polyglycerin fatty acid ester solution is not limited as long as it can dissolve the polyglycerin fatty acid ester, but alcoholic solvents such as ethanol are preferred. In order not to leave a large amount of the solvent of the polyglycerin fatty acid ester solution in the second mixture, heat treatment may be performed during or after spraying the polyglycerin fatty acid ester solution to the first mixture.
 また、第2の混合物の調製後、第2の混合物を乾燥する処理を行ってもよい(乾燥工程)。その後、冷却する処理を行ってもよい。冷却は自然冷却でもよいし、何らかの冷却手段を用いて行ってもよい(冷却工程)。乾燥を行うことで、例えば第2の混合物の含水率を5~60重量%の間の所望の数値に調整することができる。これにより組成物における含水率の調整が容易になる。 Further, after preparing the second mixture, a process of drying the second mixture may be performed (drying step). After that, a cooling process may be performed. Cooling may be natural cooling, or may be performed using some cooling means (cooling step). Drying can be used to adjust the moisture content of the second mixture to a desired value, for example between 5 and 60% by weight. This facilitates adjustment of the moisture content in the composition.
 上記のとおりに得た混合物に、必要に応じてpH調整剤を含む水溶液、アセスルファムカリウム等の甘味料、メンソール等の香料、大豆レシチン等の苦味抑制剤、またはグリセリン等の保湿剤を添加(添加剤添加工程)することができる。上記の添加物は、固体で添加してもよいし、水に溶解した水溶液として添加してもよい。水溶液で添加する場合は、オーラル製品の最終水分含量を達成できるように予め所定量の水に溶解して添加してもよい。 To the mixture obtained as described above, an aqueous solution containing a pH adjuster, a sweetener such as acesulfame potassium, a flavoring agent such as menthol, a bitterness inhibitor such as soybean lecithin, or a humectant such as glycerin is added (addition agent addition step). The above additives may be added as solids or as an aqueous solution dissolved in water. When added in the form of an aqueous solution, it may be dissolved in a predetermined amount of water in advance and added so as to achieve the final moisture content of the oral product.
(2)オーラル製品の製造
 前記組成物を公知の方法で加工してオーラル製品とすることができる。以下、オーラルパウチ製品を例にして説明する。
(2) Production of oral products The composition can be processed by a known method to produce oral products. The oral pouch product will be described below as an example.
 前記組成物を外装材で包装することでオーラルパウチ製品を製造できる(包装工程)。包装する方法は限定されず、公知の方法を適用することができる。例えば、袋形状の不織布に前記組成物を投入した後シールする方法等、公知の方法を用いることができる。包装工程において、シール後に所望のさらに水を加えてもよい(水添加工程)。例えば、最終的な組成物の水の含有率が50重量%であり、充填された組成物の水の含有率が15重量%である場合は、残りの35重量%分の水を添加する。 An oral pouch product can be manufactured by packaging the composition with an exterior material (packaging process). The packaging method is not limited, and known methods can be applied. For example, a known method can be used, such as a method in which the composition is put into a bag-shaped nonwoven fabric and then sealed. In the packaging process, additional water may be added as desired after sealing (water addition step). For example, if the water content of the final composition is 50% by weight and the water content of the filled composition is 15% by weight, the remaining 35% by weight of water is added.
4.摂取方法
 前記製品は、グルコースの摂取中または摂取後に、当該グルコース100重量部に対し、3~7重量部の前記難消化デキストリンを摂取するように使用される。具体的には、グルコースの摂取中または摂取後に口内に製品を入れて使用する。難消化デキストリンによって血糖値抑制効果が期待される。例えば、食後にたばこを嗜むことは多くなされているため本発明のオーラル製品は食後に使用されることが好ましい。食後とは、一態様において食事終了後0~30分をいう。
4. Method of ingestion The product is used so that 3-7 parts by weight of the indigestible dextrin is ingested per 100 parts by weight of glucose during or after ingestion of glucose. Specifically, the product is used by placing it in the mouth during or after ingestion of glucose. Indigestible dextrin is expected to have the effect of suppressing blood sugar levels. For example, since many people enjoy smoking after meals, the oral product of the present invention is preferably used after meals. Postprandial refers in one aspect to 0 to 30 minutes after the end of a meal.
 本発明における各特性の測定は、測定前に、測定する環境と同様の環境に測定サンプルを48時間以上保持して実施される。また、測定温度、測定湿度、および測定圧力については、特に断りのない限り、常温(25±2℃)、常湿(60±5%RH)、および常圧(大気圧)である。 The measurement of each characteristic in the present invention is carried out by holding the measurement sample in the same environment as the environment to be measured for 48 hours or more before measurement. In addition, unless otherwise specified, the temperature, humidity, and pressure to be measured are normal temperature (25±2° C.), normal humidity (60±5% RH), and normal pressure (atmospheric pressure).
[実施例1]
 以下に示す成分をミキサーで混合して、オーラル製品用組成物を製造する。
  ニコチン 2重量部
  難消化デキストリン 800重量部
  ペクチン 2.1重量部
  マルチトール 37.8重量部
  セルロース 22.7重量部
  リン酸ナトリウム 14.3重量部
  ポリグリセリン脂肪酸エステル 10.3重量部
  シリカ 2.1重量部
  アセスルファムK 0.3重量部
[Example 1]
The following ingredients are mixed in a mixer to produce an oral product composition.
Nicotine 2 parts by weight Indigestible dextrin 800 parts by weight Pectin 2.1 parts by weight Maltitol 37.8 parts by weight Cellulose 22.7 parts by weight Sodium phosphate 14.3 parts by weight Polyglycerin fatty acid ester 10.3 parts by weight Silica 2.1 parts by weight Parts by weight Acesulfame K 0.3 parts by weight
[実施例2]
 実施例1で得た組成物0.7gを採取し、これを公知のパウチで包装してオーラルパウチ製品を製造する。当該製品1個当たりのニコチン含有量は1.6mg、難消化デキストリン量は0.65gである。
[Example 2]
0.7 g of the composition obtained in Example 1 is collected and packed in a known pouch to produce an oral pouch product. The nicotine content per one product is 1.6 mg, and the amount of indigestible dextrin is 0.65 g.

Claims (9)

  1.  ニコチンまたはニコチン含有原料(A)と、難消化デキストリン(B)と、を含み、
     グルコース摂取中または摂取後に、当該グルコース100重量部に対し、3~7重量部の前記難消化デキストリンを摂取できるオーラル製品用組成物。
    nicotine or a nicotine-containing raw material (A) and an indigestible dextrin (B),
    A composition for oral products, in which 3 to 7 parts by weight of the indigestible dextrin can be ingested with respect to 100 parts by weight of the glucose during or after the ingestion of glucose.
  2.  請求項1に記載の組成物を含有するオーラル製品であって、当該製品当たりの前記難消化デキストリン(B)の重量が3~9gである、オーラル製品。 An oral product containing the composition according to claim 1, wherein the weight of the indigestible dextrin (B) per product is 3-9 g.
  3.  請求項1に記載の組成物を含有するオーラル製品であって、当該製品当たりの前記難消化デキストリン(B)の重量が0.5~1gである、オーラル製品。 An oral product containing the composition according to claim 1, wherein the weight of the indigestible dextrin (B) per product is 0.5-1 g.
  4.  ニコチンまたはニコチン含有原料(A)を含む主材と、
     当該主材の外側に設けられた外装材と、を備え、
     前記外装材または前記主材が難消化デキストリン(B)をさらに含有し、
     前記難消化デキストリン(B)の量が当該製品中3~9gである、
    オーラル製品。
    a main material containing nicotine or a nicotine-containing raw material (A);
    and an exterior material provided outside the main material,
    The exterior material or the main material further contains indigestible dextrin (B),
    The amount of the indigestible dextrin (B) is 3 to 9 g in the product,
    oral products.
  5.  ニコチンまたはニコチン含有原料(A)を含む主材と、
     当該主材の外側に設けられた外装材と、を備え、
     前記外装材または前記充填物が難消化デキストリン(B)をさらに含有し、
     前記難消化デキストリン(B)の量が当該製品中0.5~1gである、
    オーラル製品。
    a main material containing nicotine or a nicotine-containing raw material (A);
    and an exterior material provided outside the main material,
    The exterior material or the filling further contains a non-digestible dextrin (B),
    The amount of the indigestible dextrin (B) is 0.5 to 1 g in the product,
    oral products.
  6.  噛みたばこ、パウチ、錠剤、ガム、フィルム、または液体の形態である、請求項2または3に記載のオーラル製品。 The oral product according to claim 2 or 3, which is in chewing tobacco, pouch, tablet, gum, film or liquid form.
  7.  ガムまたは錠剤の形態である、請求項2または4に記載のオーラル製品。 The oral product according to claim 2 or 4, which is in the form of gum or tablet.
  8.  パウチの形態である、請求項3または5に記載のオーラル製品。 The oral product according to claim 3 or 5, which is in the form of a pouch.
  9.  請求項2~8のいずれかに記載の製品の摂取方法であって、
     グルコースの摂取中または摂取後に、当該グルコース100重量部に対し、3~7重量部の前記難消化デキストリンを摂取する、摂取方法。
    A method of ingesting the product according to any one of claims 2 to 8,
    A method of ingestion, comprising ingesting 3 to 7 parts by weight of the indigestible dextrin with respect to 100 parts by weight of the glucose during or after the ingestion of glucose.
PCT/JP2021/040024 2021-10-29 2021-10-29 Oral product containing indigestible dextrin and composition for said product WO2023073922A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2021/040024 WO2023073922A1 (en) 2021-10-29 2021-10-29 Oral product containing indigestible dextrin and composition for said product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2021/040024 WO2023073922A1 (en) 2021-10-29 2021-10-29 Oral product containing indigestible dextrin and composition for said product

Publications (1)

Publication Number Publication Date
WO2023073922A1 true WO2023073922A1 (en) 2023-05-04

Family

ID=86157637

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/040024 WO2023073922A1 (en) 2021-10-29 2021-10-29 Oral product containing indigestible dextrin and composition for said product

Country Status (1)

Country Link
WO (1) WO2023073922A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009046448A (en) * 2007-08-22 2009-03-05 Japan Tobacco Inc Blood glucose level rise-suppressing agent for ingestion after eating, and food in which blood glucose level rise-suppressing agent for ingestion after eating is formulated, containing the same agent
JP2010018528A (en) * 2008-07-09 2010-01-28 Matsutani Chem Ind Ltd Biological function improving composition comprising dietary fiber and rare sugar
JP2012528854A (en) * 2009-06-25 2012-11-15 チャバイオ アンド ディオステク株式会社 Oral fast-dissolving film that effectively masks unpleasant taste
JP2013507105A (en) * 2009-10-09 2013-03-04 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Wet smokeless tobacco product with textured coating
JP2015503931A (en) * 2012-01-20 2015-02-05 アルトリア クライアント サービシーズ インコーポレイテッドAltria Client Services Inc. Oral products
JP2016528930A (en) * 2013-09-09 2016-09-23 アール・ジエイ・レイノルズ・タバコ・カンパニー Smokeless tobacco composition incorporating plant material
CN106617262A (en) * 2016-12-14 2017-05-10 湖北中烟工业有限责任公司 Tobacco buccal tablet and preparation method thereof
JP2019202995A (en) * 2018-05-17 2019-11-28 大正製薬株式会社 Oral composition

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009046448A (en) * 2007-08-22 2009-03-05 Japan Tobacco Inc Blood glucose level rise-suppressing agent for ingestion after eating, and food in which blood glucose level rise-suppressing agent for ingestion after eating is formulated, containing the same agent
JP2010018528A (en) * 2008-07-09 2010-01-28 Matsutani Chem Ind Ltd Biological function improving composition comprising dietary fiber and rare sugar
JP2012528854A (en) * 2009-06-25 2012-11-15 チャバイオ アンド ディオステク株式会社 Oral fast-dissolving film that effectively masks unpleasant taste
JP2013507105A (en) * 2009-10-09 2013-03-04 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Wet smokeless tobacco product with textured coating
JP2015503931A (en) * 2012-01-20 2015-02-05 アルトリア クライアント サービシーズ インコーポレイテッドAltria Client Services Inc. Oral products
JP2016528930A (en) * 2013-09-09 2016-09-23 アール・ジエイ・レイノルズ・タバコ・カンパニー Smokeless tobacco composition incorporating plant material
CN106617262A (en) * 2016-12-14 2017-05-10 湖北中烟工业有限责任公司 Tobacco buccal tablet and preparation method thereof
JP2019202995A (en) * 2018-05-17 2019-11-28 大正製薬株式会社 Oral composition

Similar Documents

Publication Publication Date Title
RU2704937C2 (en) Aromatic capsules for smoking articles
US20170280764A1 (en) An oral smokeless moist snuff product
US20180279666A1 (en) Aerosol generating material and devices including the same
SE532935C2 (en) Smoke-free oral tobacco composition and methods for making the same
CN112021652B (en) Core-shell structure blasting bead for cigarettes and preparation method thereof
WO2021220898A1 (en) Nicotine supply oral pouch product and production method therefor
JP2014205632A (en) High concentration ethyl-3-(p-menthane-3-carboxamide) acetate-containing powdery flavoring preparation
CN115335080A (en) Novel oral or nasal composition
WO2023073922A1 (en) Oral product containing indigestible dextrin and composition for said product
US20220386684A1 (en) Aerosol-Generating Tobacco-Containing Composition Comprising Medium-Chain Triglyceride
SE0702434A1 (en) Non-smoking oral tobacco composition and methods of making the same
WO2022210840A1 (en) Oral pouch product and oral pouch product manufacturing method
WO2024053004A1 (en) Oral pouch product containing amino acid or salt thereof
JP5871609B2 (en) High concentration menthol-containing powder flavor preparation
WO2023210805A1 (en) Oral cavity composition containing organic material
WO2023112150A1 (en) Oral product containing low molecular weight alginic acid compound and composition for said product
WO2010010894A1 (en) Flavor-improving agent for menthol and method for improving flavor of manthol
WO2023106389A1 (en) Composition to be used in mouth, and pouch product to be used in mouth
WO2023210813A1 (en) Oral composition containing inorganic porous material
WO2023210814A1 (en) Oral composition containing inorganic porous material
WO2023210810A1 (en) Oral composition
JP2024513466A (en) Oral pouch products
WO2022210842A1 (en) Oral pouch product
WO2022210841A1 (en) Pouch product for use in oral cavity and method for manufacturing same
WO2023210812A1 (en) Oral-cavity composition containing porous material

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21962464

Country of ref document: EP

Kind code of ref document: A1